primaryid,caseid,drug_seq,role_cod,drugname,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,mfr_num,mfr_sndr,age,age_cod,gndr_cod,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
73215083,7321508,7,C,EXENATIDE(EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Glomerular filtration rate decreased,2013,Q1,3,F,,20121002.0,20100219,20121016,EXP,AUR-APL-2010-00361,AUROBINDO,63.0,YR,M,N,68.7,KG,20121015.0,,OT,COUNTRY NOT SPECIFIED,,2013,Q1,Adult
73215083,7321508,7,C,EXENATIDE(EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Renal impairment,2013,Q1,3,F,,20121002.0,20100219,20121016,EXP,AUR-APL-2010-00361,AUROBINDO,63.0,YR,M,N,68.7,KG,20121015.0,,OT,COUNTRY NOT SPECIFIED,,2013,Q1,Adult
87602932,8760293,7,C,BYETTA(EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Bladder cancer,2013,Q1,2,F,201008.0,20130129.0,20120817,20130206,EXP,TPA2012A05442,TAKEDA,72.0,YR,M,N,200.0,LBS,20130205.0,,OT,US,,2013,Q1,Elderly
87602932,8760293,7,C,BYETTA(EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Metastatic carcinoma of the bladder,2013,Q1,2,F,201008.0,20130129.0,20120817,20130206,EXP,TPA2012A05442,TAKEDA,72.0,YR,M,N,200.0,LBS,20130205.0,,OT,US,,2013,Q1,Elderly
88301032,8830103,3,SS,EXENATIDE,1,,,,,,,,,,,,,,2013,Q1,Abdominal pain,2013,Q1,2,F,,20130219.0,20121004,20130305,EXP,AUR-APL-2012-04226,AUROBINDO,54.0,YR,M,N,235.0,LBS,20130304.0,,RN,US,,2013,Q1,Adult
88301032,8830103,3,SS,EXENATIDE,1,,,,,,,,,,,,,,2013,Q1,Decreased appetite,2013,Q1,2,F,,20130219.0,20121004,20130305,EXP,AUR-APL-2012-04226,AUROBINDO,54.0,YR,M,N,235.0,LBS,20130304.0,,RN,US,,2013,Q1,Adult
88301032,8830103,3,SS,EXENATIDE,1,,,,,,,,,,,,,,2013,Q1,Eating disorder,2013,Q1,2,F,,20130219.0,20121004,20130305,EXP,AUR-APL-2012-04226,AUROBINDO,54.0,YR,M,N,235.0,LBS,20130304.0,,RN,US,,2013,Q1,Adult
88301032,8830103,3,SS,EXENATIDE,1,,,,,,,,,,,,,,2013,Q1,Pancreatic insufficiency,2013,Q1,2,F,,20130219.0,20121004,20130305,EXP,AUR-APL-2012-04226,AUROBINDO,54.0,YR,M,N,235.0,LBS,20130304.0,,RN,US,,2013,Q1,Adult
88301032,8830103,3,SS,EXENATIDE,1,,,,,,,,,,,,,,2013,Q1,Pancreatitis,2013,Q1,2,F,,20130219.0,20121004,20130305,EXP,AUR-APL-2012-04226,AUROBINDO,54.0,YR,M,N,235.0,LBS,20130304.0,,RN,US,,2013,Q1,Adult
88301032,8830103,3,SS,EXENATIDE,1,,,,,,,,,,,,,,2013,Q1,Weight decreased,2013,Q1,2,F,,20130219.0,20121004,20130305,EXP,AUR-APL-2012-04226,AUROBINDO,54.0,YR,M,N,235.0,LBS,20130304.0,,RN,US,,2013,Q1,Adult
89153542,8915354,1,PS,EXENATIDE LONG ACTING RELEASE 2mg,1,UNKNOWN,"UNK, WEEKLY (1/W)",,,,Y,,,22200.0,,,INJECTION,/wk,2013,Q1,Gastroenteritis,2013,Q1,2,F,20120814.0,20130206.0,20121116,20130220,EXP,AU-ELI_LILLY_AND_COMPANY-AU201208007909,ELI LILLY AND CO,58.0,YR,F,Y,91.0,KG,20130218.0,,MD,AU,AU,2013,Q1,Adult
89153542,8915354,2,SS,EXENATIDE LONG ACTING RELEASE 2mg,1,,"UNK, WEEKLY (1/W)",,,,Y,,,22200.0,,,INJECTION,/wk,2013,Q1,Gastroenteritis,2013,Q1,2,F,20120814.0,20130206.0,20121116,20130220,EXP,AU-ELI_LILLY_AND_COMPANY-AU201208007909,ELI LILLY AND CO,58.0,YR,F,Y,91.0,KG,20130218.0,,MD,AU,AU,2013,Q1,Adult
90003541,9000354,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Pancreatitis,2013,Q1,1,I,20090909.0,,20130102,20130102,DIR,,,59.0,YR,M,N,130.2,KG,20091106.0,,PH,US,,2013,Q1,Adult
90317261,9031726,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Abdominal pain,2013,Q1,1,I,,20130121.0,20130124,20130124,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301006798,ELI LILLY AND CO,80.0,YR,M,Y,,,20130124.0,,CN,GB,GB,2013,Q1,Elderly
90317261,9031726,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Liver function test abnormal,2013,Q1,1,I,,20130121.0,20130124,20130124,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301006798,ELI LILLY AND CO,80.0,YR,M,Y,,,20130124.0,,CN,GB,GB,2013,Q1,Elderly
90317261,9031726,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Multi-organ failure,2013,Q1,1,I,,20130121.0,20130124,20130124,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301006798,ELI LILLY AND CO,80.0,YR,M,Y,,,20130124.0,,CN,GB,GB,2013,Q1,Elderly
90317261,9031726,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Pancreatitis,2013,Q1,1,I,,20130121.0,20130124,20130124,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301006798,ELI LILLY AND CO,80.0,YR,M,Y,,,20130124.0,,CN,GB,GB,2013,Q1,Elderly
90317261,9031726,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Renal failure acute,2013,Q1,1,I,,20130121.0,20130124,20130124,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301006798,ELI LILLY AND CO,80.0,YR,M,Y,,,20130124.0,,CN,GB,GB,2013,Q1,Elderly
90317261,9031726,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Syncope,2013,Q1,1,I,,20130121.0,20130124,20130124,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301006798,ELI LILLY AND CO,80.0,YR,M,Y,,,20130124.0,,CN,GB,GB,2013,Q1,Elderly
90463081,9046308,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Nausea,2013,Q1,1,I,20121204.0,,20130128,20130128,DIR,,,70.0,YR,M,N,126.5,KG,20130114.0,,PH,US,,2013,Q1,Elderly
90463081,9046308,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Vomiting,2013,Q1,1,I,20121204.0,,20130128,20130128,DIR,,,70.0,YR,M,N,126.5,KG,20130114.0,,PH,US,,2013,Q1,Elderly
90505411,9050541,1,PS,EXENATIDE,1,,"10 UG, BID",,,,U,,,21773.0,10,UG,,BID,2013,Q1,Blood glucose increased,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,1,PS,EXENATIDE,1,,"10 UG, BID",,,,U,,,21773.0,10,UG,,BID,2013,Q1,Intentional overdose,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,1,PS,EXENATIDE,1,,"10 UG, BID",,,,U,,,21773.0,10,UG,,BID,2013,Q1,Nausea,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,1,PS,EXENATIDE,1,,"10 UG, BID",,,,U,,,21773.0,10,UG,,BID,2013,Q1,Vomiting,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,2,SS,EXENATIDE,1,,"1800 UG, SINGLE",,,,U,,,21773.0,1800,UG,,,2013,Q1,Blood glucose increased,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,2,SS,EXENATIDE,1,,"1800 UG, SINGLE",,,,U,,,21773.0,1800,UG,,,2013,Q1,Intentional overdose,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,2,SS,EXENATIDE,1,,"1800 UG, SINGLE",,,,U,,,21773.0,1800,UG,,,2013,Q1,Nausea,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90505411,9050541,2,SS,EXENATIDE,1,,"1800 UG, SINGLE",,,,U,,,21773.0,1800,UG,,,2013,Q1,Vomiting,2013,Q1,1,I,,20130122.0,20130205,20130205,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008181,ELI LILLY AND CO,46.0,YR,F,Y,,,20130201.0,,MD,GB,GB,2013,Q1,Adult
90577251,9057725,1,PS,EXENATIDE,1,ORAL,,,,Y,D,,,,10,MG,,BID,2013,Q1,Amylase increased,2013,Q1,1,I,20121023.0,,20130204,20130204,DIR,,,66.0,YR,M,N,98.9,KG,20121128.0,,PH,US,,2013,Q1,Elderly
90577251,9057725,1,PS,EXENATIDE,1,ORAL,,,,Y,D,,,,10,MG,,BID,2013,Q1,Hepatic enzyme increased,2013,Q1,1,I,20121023.0,,20130204,20130204,DIR,,,66.0,YR,M,N,98.9,KG,20121128.0,,PH,US,,2013,Q1,Elderly
90577251,9057725,1,PS,EXENATIDE,1,ORAL,,,,Y,D,,,,10,MG,,BID,2013,Q1,Lipase increased,2013,Q1,1,I,20121023.0,,20130204,20130204,DIR,,,66.0,YR,M,N,98.9,KG,20121128.0,,PH,US,,2013,Q1,Elderly
90898231,9089823,1,PS,EXENATIDE,1,,UNK,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Granuloma,2013,Q1,1,I,20130117.0,20130128.0,20130201,20130201,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008852,ELI LILLY AND CO,53.0,YR,F,Y,103,KG,20130131.0,,CN,GB,GB,2013,Q1,Adult
90898231,9089823,1,PS,EXENATIDE,1,,UNK,,,,D,,,21773.0,,,INJECTION,,2013,Q1,Injection site mass,2013,Q1,1,I,20130117.0,20130128.0,20130201,20130201,EXP,GB-ELI_LILLY_AND_COMPANY-GB201301008852,ELI LILLY AND CO,53.0,YR,F,Y,103,KG,20130131.0,,CN,GB,GB,2013,Q1,Adult
90970832,9097083,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Bladder cancer,2013,Q1,2,F,,20130313.0,20130125,20130318,EXP,TPA2013A00908,TAKEDA,78.0,YR,M,N,,,20130315.0,,OT,US,,2013,Q1,Elderly
91309161,9130916,7,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q1,Blood glucose increased,2013,Q1,1,I,,20130219.0,20130301,20130301,EXP,2013SP002577,STRIDES,54.0,YR,M,Y,,,20130301.0,,OT,US,US,2013,Q1,Adult
91309161,9130916,7,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q1,Blood lactic acid increased,2013,Q1,1,I,,20130219.0,20130301,20130301,EXP,2013SP002577,STRIDES,54.0,YR,M,Y,,,20130301.0,,OT,US,US,2013,Q1,Adult
91309161,9130916,7,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q1,Nausea,2013,Q1,1,I,,20130219.0,20130301,20130301,EXP,2013SP002577,STRIDES,54.0,YR,M,Y,,,20130301.0,,OT,US,US,2013,Q1,Adult
91403071,9140307,3,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q1,Pancreatic carcinoma,2013,Q1,1,I,,20130222.0,20130305,20130305,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-17432543,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,102,KG,20130305.0,,CN,DE,US,2013,Q1,Adult
91403071,9140307,3,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q1,Pancreatic insufficiency,2013,Q1,1,I,,20130222.0,20130305,20130305,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-17432543,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,102,KG,20130305.0,,CN,DE,US,2013,Q1,Adult
91524461,9152446,1,PS,EXENATIDE,1,,"UNK UNK, UNKNOWN",,,,D,,,21773.0,,,,,2013,Q1,Dyspnoea,2013,Q1,1,I,,20130304.0,20130308,20130308,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303001237,ELI LILLY AND CO,43.0,YR,F,Y,,,20130308.0,,CN,GB,GB,2013,Q1,Adult
91524461,9152446,1,PS,EXENATIDE,1,,"UNK UNK, UNKNOWN",,,,D,,,21773.0,,,,,2013,Q1,Mobility decreased,2013,Q1,1,I,,20130304.0,20130308,20130308,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303001237,ELI LILLY AND CO,43.0,YR,F,Y,,,20130308.0,,CN,GB,GB,2013,Q1,Adult
91569531,9156953,2,SS,EXENATIDE (EXENATIDE),1,,,,,D,D,,,,5,UG,,BID,2013,Q1,Adrenal insufficiency,2013,Q1,1,I,,20130131.0,20130212,20130212,EXP,7191312,MERCK KGAA,50.0,YR,F,N,,,20130206.0,,OT,JP,,2013,Q1,Adult
91569531,9156953,2,SS,EXENATIDE (EXENATIDE),1,,,,,D,D,,,,5,UG,,BID,2013,Q1,Decreased appetite,2013,Q1,1,I,,20130131.0,20130212,20130212,EXP,7191312,MERCK KGAA,50.0,YR,F,N,,,20130206.0,,OT,JP,,2013,Q1,Adult
91569531,9156953,2,SS,EXENATIDE (EXENATIDE),1,,,,,D,D,,,,5,UG,,BID,2013,Q1,Fatigue,2013,Q1,1,I,,20130131.0,20130212,20130212,EXP,7191312,MERCK KGAA,50.0,YR,F,N,,,20130206.0,,OT,JP,,2013,Q1,Adult
91569531,9156953,2,SS,EXENATIDE (EXENATIDE),1,,,,,D,D,,,,5,UG,,BID,2013,Q1,Hypotension,2013,Q1,1,I,,20130131.0,20130212,20130212,EXP,7191312,MERCK KGAA,50.0,YR,F,N,,,20130206.0,,OT,JP,,2013,Q1,Adult
91569531,9156953,2,SS,EXENATIDE (EXENATIDE),1,,,,,D,D,,,,5,UG,,BID,2013,Q1,Iatrogenic injury,2013,Q1,1,I,,20130131.0,20130212,20130212,EXP,7191312,MERCK KGAA,50.0,YR,F,N,,,20130206.0,,OT,JP,,2013,Q1,Adult
91606951,9160695,8,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Blepharospasm,2013,Q1,1,I,201211.0,20130131.0,20130215,20130215,EXP,VER-2013-00044,VEROSCIENCE,48.0,YR,M,N,275,LBS,20130214.0,,CN,US,,2013,Q1,Adult
91606951,9160695,8,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Muscle rigidity,2013,Q1,1,I,201211.0,20130131.0,20130215,20130215,EXP,VER-2013-00044,VEROSCIENCE,48.0,YR,M,N,275,LBS,20130214.0,,CN,US,,2013,Q1,Adult
91606951,9160695,8,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Parkinson's disease,2013,Q1,1,I,201211.0,20130131.0,20130215,20130215,EXP,VER-2013-00044,VEROSCIENCE,48.0,YR,M,N,275,LBS,20130214.0,,CN,US,,2013,Q1,Adult
91606951,9160695,8,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Tremor,2013,Q1,1,I,201211.0,20130131.0,20130215,20130215,EXP,VER-2013-00044,VEROSCIENCE,48.0,YR,M,N,275,LBS,20130214.0,,CN,US,,2013,Q1,Adult
91634251,9163425,1,PS,EXENATIDE,1,,"UNK, UNKNOWN",,,,U,,,21773.0,,,,,2013,Q1,Hepatic function abnormal,2013,Q1,1,I,20130219.0,20130304.0,20130314,20130314,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303000836,ELI LILLY AND CO,58.0,YR,M,Y,148.8,KG,20130313.0,,CN,GB,GB,2013,Q1,Adult
91893831,9189383,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Bladder cancer,2013,Q1,1,I,2003.0,20130315.0,20130322,20130322,EXP,TPA2013A02205,TAKEDA,58.0,YR,M,N,207,LBS,20130320.0,,,US,,2013,Q1,Adult
91893831,9189383,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Cystitis,2013,Q1,1,I,2003.0,20130315.0,20130322,20130322,EXP,TPA2013A02205,TAKEDA,58.0,YR,M,N,207,LBS,20130320.0,,,US,,2013,Q1,Adult
91893831,9189383,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Pollakiuria,2013,Q1,1,I,2003.0,20130315.0,20130322,20130322,EXP,TPA2013A02205,TAKEDA,58.0,YR,M,N,207,LBS,20130320.0,,,US,,2013,Q1,Adult
91984281,9198428,2,SS,EXENATIDE,1,SUBCUTANEOUS,10 UG BID SQ,,,N,D,,,,10,UG,,BID,2013,Q1,Pancreatic carcinoma,2013,Q1,1,I,20130322.0,,20130327,20130327,DIR,,,63.0,YR,F,N,58.5,LBS,20130326.0,Y,OT,US,,2013,Q1,Adult
91984281,9198428,2,SS,EXENATIDE,1,SUBCUTANEOUS,10 UG BID SQ,,,N,D,,,,10,UG,,BID,2013,Q1,Pancreatitis,2013,Q1,1,I,20130322.0,,20130327,20130327,DIR,,,63.0,YR,F,N,58.5,LBS,20130326.0,Y,OT,US,,2013,Q1,Adult
91984281,9198428,2,SS,EXENATIDE,1,SUBCUTANEOUS,10 UG BID SQ,,,N,D,,,,10,UG,,BID,2013,Q1,Tumour necrosis,2013,Q1,1,I,20130322.0,,20130327,20130327,DIR,,,63.0,YR,F,N,58.5,LBS,20130326.0,Y,OT,US,,2013,Q1,Adult
92046141,9204614,3,C,BYETTA (EXENATIDE) - (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Fatigue,2013,Q1,1,I,20120409.0,20120522.0,20120709,20120709,PER,2012HGS-003490,HUMAN GENOME SCIENCES,42.0,YR,F,N,245,LBS,20120622.0,,,US,,2013,Q1,Adult
92046141,9204614,3,C,BYETTA (EXENATIDE) - (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Headache,2013,Q1,1,I,20120409.0,20120522.0,20120709,20120709,PER,2012HGS-003490,HUMAN GENOME SCIENCES,42.0,YR,F,N,245,LBS,20120622.0,,,US,,2013,Q1,Adult
92046141,9204614,3,C,BYETTA (EXENATIDE) - (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Infusion related reaction,2013,Q1,1,I,20120409.0,20120522.0,20120709,20120709,PER,2012HGS-003490,HUMAN GENOME SCIENCES,42.0,YR,F,N,245,LBS,20120622.0,,,US,,2013,Q1,Adult
92046141,9204614,3,C,BYETTA (EXENATIDE) - (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Nausea,2013,Q1,1,I,20120409.0,20120522.0,20120709,20120709,PER,2012HGS-003490,HUMAN GENOME SCIENCES,42.0,YR,F,N,245,LBS,20120622.0,,,US,,2013,Q1,Adult
92058461,9205846,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,10,UG,,BID,2013,Q1,Abdominal discomfort,2013,Q1,1,I,201205.0,20120606.0,20120731,20120731,PER,US201206001903,ELI LILLY AND CO,50.0,YR,M,N,,,,,MD,US,,2013,Q1,Adult
92058461,9205846,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,10,UG,,BID,2013,Q1,Abdominal pain,2013,Q1,1,I,201205.0,20120606.0,20120731,20120731,PER,US201206001903,ELI LILLY AND CO,50.0,YR,M,N,,,,,MD,US,,2013,Q1,Adult
92058461,9205846,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,10,UG,,BID,2013,Q1,Headache,2013,Q1,1,I,201205.0,20120606.0,20120731,20120731,PER,US201206001903,ELI LILLY AND CO,50.0,YR,M,N,,,,,MD,US,,2013,Q1,Adult
92058461,9205846,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,10,UG,,BID,2013,Q1,Nausea,2013,Q1,1,I,201205.0,20120606.0,20120731,20120731,PER,US201206001903,ELI LILLY AND CO,50.0,YR,M,N,,,,,MD,US,,2013,Q1,Adult
92058461,9205846,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,10,UG,,BID,2013,Q1,Pancreatitis,2013,Q1,1,I,201205.0,20120606.0,20120731,20120731,PER,US201206001903,ELI LILLY AND CO,50.0,YR,M,N,,,,,MD,US,,2013,Q1,Adult
92058461,9205846,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,10,UG,,BID,2013,Q1,Vomiting,2013,Q1,1,I,201205.0,20120606.0,20120731,20120731,PER,US201206001903,ELI LILLY AND CO,50.0,YR,M,N,,,,,MD,US,,2013,Q1,Adult
92060431,9206043,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,N,,,21773.0,5,UG,,BID,2013,Q1,Urticaria,2013,Q1,1,I,20120501.0,20120627.0,20120731,20120731,PER,US201205002638,ELI LILLY AND CO,63.0,YR,F,N,91.6,KG,20120709.0,,RN,US,,2013,Q1,Adult
92060431,9206043,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,N,,,21773.0,5,UG,,BID,2013,Q1,Weight decreased,2013,Q1,1,I,20120501.0,20120627.0,20120731,20120731,PER,US201205002638,ELI LILLY AND CO,63.0,YR,F,N,91.6,KG,20120709.0,,RN,US,,2013,Q1,Adult
92060741,9206074,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,BID,2013,Q1,Blood glucose increased,2013,Q1,1,I,20120518.0,20120524.0,20120731,20120731,PER,US201205009027,ELI LILLY AND CO,53.0,YR,F,N,115.6,KG,20120709.0,,OT,US,,2013,Q1,Adult
92060741,9206074,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,BID,2013,Q1,Dyspepsia,2013,Q1,1,I,20120518.0,20120524.0,20120731,20120731,PER,US201205009027,ELI LILLY AND CO,53.0,YR,F,N,115.6,KG,20120709.0,,OT,US,,2013,Q1,Adult
92060741,9206074,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,BID,2013,Q1,Pancreatitis,2013,Q1,1,I,20120518.0,20120524.0,20120731,20120731,PER,US201205009027,ELI LILLY AND CO,53.0,YR,F,N,115.6,KG,20120709.0,,OT,US,,2013,Q1,Adult
92061101,9206110,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Drug effect decreased,2013,Q1,1,I,,20120605.0,20120731,20120731,PER,US200811003362,ELI LILLY AND CO,58.0,YR,M,N,82.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061101,9206110,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Nausea,2013,Q1,1,I,,20120605.0,20120731,20120731,PER,US200811003362,ELI LILLY AND CO,58.0,YR,M,N,82.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061101,9206110,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Off label use,2013,Q1,1,I,,20120605.0,20120731,20120731,PER,US200811003362,ELI LILLY AND CO,58.0,YR,M,N,82.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061101,9206110,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Weight decreased,2013,Q1,1,I,,20120605.0,20120731,20120731,PER,US200811003362,ELI LILLY AND CO,58.0,YR,M,N,82.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061211,9206121,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Blood glucose decreased,2013,Q1,1,I,,20120524.0,20120731,20120731,PER,US201110003140,ELI LILLY AND CO,64.0,YR,F,N,146.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061211,9206121,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Blood glucose increased,2013,Q1,1,I,,20120524.0,20120731,20120731,PER,US201110003140,ELI LILLY AND CO,64.0,YR,F,N,146.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061211,9206121,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Decreased appetite,2013,Q1,1,I,,20120524.0,20120731,20120731,PER,US201110003140,ELI LILLY AND CO,64.0,YR,F,N,146.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061211,9206121,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Hypersensitivity,2013,Q1,1,I,,20120524.0,20120731,20120731,PER,US201110003140,ELI LILLY AND CO,64.0,YR,F,N,146.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061211,9206121,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Sinusitis,2013,Q1,1,I,,20120524.0,20120731,20120731,PER,US201110003140,ELI LILLY AND CO,64.0,YR,F,N,146.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061211,9206121,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Weight decreased,2013,Q1,1,I,,20120524.0,20120731,20120731,PER,US201110003140,ELI LILLY AND CO,64.0,YR,F,N,146.5,KG,20120709.0,,CN,US,,2013,Q1,Adult
92061291,9206129,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,,2013,Q1,Nausea,2013,Q1,1,I,,20120405.0,20120731,20120731,PER,US20111004126,ELI LILLY AND CO,70.0,YR,F,N,65.8,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92061291,9206129,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,,2013,Q1,Weight decreased,2013,Q1,1,I,,20120405.0,20120731,20120731,PER,US20111004126,ELI LILLY AND CO,70.0,YR,F,N,65.8,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92061291,9206129,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",2,,,,,,,,,,,,,,2013,Q1,Nausea,2013,Q1,1,I,,20120405.0,20120731,20120731,PER,US20111004126,ELI LILLY AND CO,70.0,YR,F,N,65.8,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92061291,9206129,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",2,,,,,,,,,,,,,,2013,Q1,Weight decreased,2013,Q1,1,I,,20120405.0,20120731,20120731,PER,US20111004126,ELI LILLY AND CO,70.0,YR,F,N,65.8,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92061351,9206135,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,5,UG,,BID,2013,Q1,Blood glucose fluctuation,2013,Q1,1,I,20111206.0,20120521.0,20120731,20120731,PER,US201112003524,ELI LILLY AND CO,70.0,YR,M,N,83.9,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92061351,9206135,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,5,UG,,BID,2013,Q1,Blood glucose increased,2013,Q1,1,I,20111206.0,20120521.0,20120731,20120731,PER,US201112003524,ELI LILLY AND CO,70.0,YR,M,N,83.9,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92061351,9206135,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,5,UG,,BID,2013,Q1,Nausea,2013,Q1,1,I,20111206.0,20120521.0,20120731,20120731,PER,US201112003524,ELI LILLY AND CO,70.0,YR,M,N,83.9,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065121,9206512,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,,20120402.0,20120731,20120731,PER,US201204000901,ELI LILLY AND CO,65.0,YR,F,N,,,20120709.0,,OT,US,,2013,Q1,Elderly
92065221,9206522,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,,,,,2013,Q1,Pancreatitis acute,2013,Q1,1,I,,20120410.0,20120731,20120731,PER,US201204002963,ELI LILLY AND CO,65.0,YR,M,N,,,20120709.0,,CN,US,,2013,Q1,Elderly
92065221,9206522,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,,,,,2013,Q1,Vomiting,2013,Q1,1,I,,20120410.0,20120731,20120731,PER,US201204002963,ELI LILLY AND CO,65.0,YR,M,N,,,20120709.0,,CN,US,,2013,Q1,Elderly
92065371,9206537,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,,20120413.0,20120731,20120731,PER,US201204004536,ELI LILLY AND CO,40.0,YR,M,N,,,20120709.0,,OT,US,,2013,Q1,Adult
92065531,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Blood glucose decreased,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Communication disorder,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Underdose,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Vision blurred,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q1,Weight decreased,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q1,Blood glucose decreased,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q1,Communication disorder,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q1,Underdose,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q1,Vision blurred,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92065531,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q1,Weight decreased,2013,Q1,1,I,,20120416.0,20120731,20120731,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20120709.0,,CN,US,,2013,Q1,Elderly
92415021,9241502,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Injection site haematoma,2013,Q1,1,I,20120228.0,20120314.0,20121121,20121121,PER,12000021,UPSHER-SMITH,64.0,YR,M,N,,,20121109.0,,CN,US,,2013,Q1,Adult
92415021,9241502,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Injection site haemorrhage,2013,Q1,1,I,20120228.0,20120314.0,20121121,20121121,PER,12000021,UPSHER-SMITH,64.0,YR,M,N,,,20121109.0,,CN,US,,2013,Q1,Adult
92415021,9241502,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,International normalised ratio increased,2013,Q1,1,I,20120228.0,20120314.0,20121121,20121121,PER,12000021,UPSHER-SMITH,64.0,YR,M,N,,,20121109.0,,CN,US,,2013,Q1,Adult
92443441,9244344,3,C,"BYETTA ( EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,,,,,,2013,Q1,Abdominal pain,2013,Q1,1,I,20120706.0,20120717.0,20121130,20121130,PER,US201207005508,ELI LILLY AND CO,50.0,YR,M,N,,,20121115.0,,OT,US,,2013,Q1,Adult
92443441,9244344,3,C,"BYETTA ( EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,,,,,,2013,Q1,Decreased appetite,2013,Q1,1,I,20120706.0,20120717.0,20121130,20121130,PER,US201207005508,ELI LILLY AND CO,50.0,YR,M,N,,,20121115.0,,OT,US,,2013,Q1,Adult
92443441,9244344,3,C,"BYETTA ( EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,,,,,,2013,Q1,Dehydration,2013,Q1,1,I,20120706.0,20120717.0,20121130,20121130,PER,US201207005508,ELI LILLY AND CO,50.0,YR,M,N,,,20121115.0,,OT,US,,2013,Q1,Adult
92443441,9244344,3,C,"BYETTA ( EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,,,,,,2013,Q1,Diarrhoea,2013,Q1,1,I,20120706.0,20120717.0,20121130,20121130,PER,US201207005508,ELI LILLY AND CO,50.0,YR,M,N,,,20121115.0,,OT,US,,2013,Q1,Adult
92443441,9244344,3,C,"BYETTA ( EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,,,,,,2013,Q1,Vomiting,2013,Q1,1,I,20120706.0,20120717.0,20121130,20121130,PER,US201207005508,ELI LILLY AND CO,50.0,YR,M,N,,,20121115.0,,OT,US,,2013,Q1,Adult
92443441,9244344,3,C,"BYETTA ( EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,,,,,,2013,Q1,Weight decreased,2013,Q1,1,I,20120706.0,20120717.0,20121130,20121130,PER,US201207005508,ELI LILLY AND CO,50.0,YR,M,N,,,20121115.0,,OT,US,,2013,Q1,Adult
92443551,9244355,3,C,"BYETTA (EXENATIDE, EXENATIDE)",2,,,,,,,,,,,,,,2013,Q1,Blood glucose increased,2013,Q1,1,I,201110.0,20121015.0,20121123,20121123,PER,362233,NOVO NORDISK,61.0,YR,F,N,,,20121116.0,,CN,US,,2013,Q1,Adult
92443551,9244355,3,C,"BYETTA (EXENATIDE, EXENATIDE)",2,,,,,,,,,,,,,,2013,Q1,Headache,2013,Q1,1,I,201110.0,20121015.0,20121123,20121123,PER,362233,NOVO NORDISK,61.0,YR,F,N,,,20121116.0,,CN,US,,2013,Q1,Adult
92443551,9244355,3,C,"BYETTA (EXENATIDE, EXENATIDE)",2,,,,,,,,,,,,,,2013,Q1,Nausea,2013,Q1,1,I,201110.0,20121015.0,20121123,20121123,PER,362233,NOVO NORDISK,61.0,YR,F,N,,,20121116.0,,CN,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Abdominal distension,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Abdominal pain upper,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Duodenal ulcer,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Flatulence,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Nausea,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Pancreatitis acute,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Vomiting,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92448691,9244869,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,21773.0,5,UG,,,2013,Q1,Weight decreased,2013,Q1,1,I,20120802.0,20121024.0,20121130,20121130,PER,US201208007355,ELI LILLY AND CO,50.0,YR,F,N,116.1,KG,20121115.0,,OT,US,,2013,Q1,Adult
92449301,9244930,1,PS,BYDUREON (EXENATIDE LONG ACTING RELEASE 2MG) VIAL + SYRINGE,1,SUBCUTANEOUS,1/W,,,Y,D,,,21773.0,2,MG,,,2013,Q1,Hypersensitivity,2013,Q1,1,I,20120831.0,20120911.0,20121130,20121130,PER,US201209003201,ELI LILLY AND CO,45.0,YR,F,N,,,20121115.0,,,US,,2013,Q1,Adult
92449301,9244930,1,PS,BYDUREON (EXENATIDE LONG ACTING RELEASE 2MG) VIAL + SYRINGE,1,SUBCUTANEOUS,1/W,,,Y,D,,,21773.0,2,MG,,,2013,Q1,Swelling face,2013,Q1,1,I,20120831.0,20120911.0,20121130,20121130,PER,US201209003201,ELI LILLY AND CO,45.0,YR,F,N,,,20121115.0,,,US,,2013,Q1,Adult
92449301,9244930,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q1,Hypersensitivity,2013,Q1,1,I,20120831.0,20120911.0,20121130,20121130,PER,US201209003201,ELI LILLY AND CO,45.0,YR,F,N,,,20121115.0,,,US,,2013,Q1,Adult
92449301,9244930,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q1,Swelling face,2013,Q1,1,I,20120831.0,20120911.0,20121130,20121130,PER,US201209003201,ELI LILLY AND CO,45.0,YR,F,N,,,20121115.0,,,US,,2013,Q1,Adult
92449681,9244968,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,D,D,,,,,,,,2013,Q1,Angioedema,2013,Q1,1,I,,20120919.0,20121130,20121130,PER,US201209005422,ELI LILLY AND CO,27.0,YR,F,N,,,20121115.0,,MD,US,,2013,Q1,Young Adult
92449681,9244968,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,D,D,,,,,,,,2013,Q1,Pruritus,2013,Q1,1,I,,20120919.0,20121130,20121130,PER,US201209005422,ELI LILLY AND CO,27.0,YR,F,N,,,20121115.0,,MD,US,,2013,Q1,Young Adult
92450541,9245054,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,20120724.0,20120730.0,20121130,20121130,PER,US201207009354,ELI LILLY AND CO,56.0,YR,M,N,119.3,KG,20121115.0,,OT,US,,2013,Q1,Adult
92450541,9245054,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q1,Weight decreased,2013,Q1,1,I,20120724.0,20120730.0,20121130,20121130,PER,US201207009354,ELI LILLY AND CO,56.0,YR,M,N,119.3,KG,20121115.0,,OT,US,,2013,Q1,Adult
93636591,9363659,7,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Bladder cancer,2013,Q1,1,I,20100121.0,20130227.0,20130305,20130305,EXP,TPA2012A06789,TAKEDA,66.0,YR,M,N,,,20130304.0,,OT,US,,2013,Q1,Elderly
95034511,9503451,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",2,,,,,,,,,,,,,,2013,Q1,Off label use,2013,Q1,1,I,20080322.0,20121119.0,20130130,20130130,PER,US201007007350,ELI LILLY AND CO,66.0,YR,F,N,,,20130104.0,,,US,,2013,Q1,Elderly
95034511,9503451,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",2,,,,,,,,,,,,,,2013,Q1,Pancreatitis acute,2013,Q1,1,I,20080322.0,20121119.0,20130130,20130130,PER,US201007007350,ELI LILLY AND CO,66.0,YR,F,N,,,20130104.0,,,US,,2013,Q1,Elderly
95034631,9503463,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,5,UG,,,2013,Q1,Diverticulum,2013,Q1,1,I,20051219.0,20121008.0,20130130,20130130,PER,US2012100002288,ELI LILLY AND CO,51.0,YR,F,N,,,20130104.0,,,US,,2013,Q1,Adult
95034631,9503463,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,5,UG,,,2013,Q1,Pancreatitis,2013,Q1,1,I,20051219.0,20121008.0,20130130,20130130,PER,US2012100002288,ELI LILLY AND CO,51.0,YR,F,N,,,20130104.0,,,US,,2013,Q1,Adult
95035251,9503525,3,C,"BYETTA (EXENATIDE, EXENATIDE)",2,,,,,,,,,,,,,,2013,Q1,Rash,2013,Q1,1,I,,20121120.0,20130225,20130225,PER,366155,NOVO NORDISK,45.0,YR,F,N,,,20130215.0,,,US,,2013,Q1,Adult
95035251,9503525,5,C,BYDUREON (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Rash,2013,Q1,1,I,,20121120.0,20130225,20130225,PER,366155,NOVO NORDISK,45.0,YR,F,N,,,20130215.0,,,US,,2013,Q1,Adult
95035691,9503569,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,,D,,,21773.0,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,,20121210.0,20130130,20130130,PER,US201212002700,ELI LILLY AND CO,69.0,YR,F,N,,,20130104.0,,MD,US,,2013,Q1,Elderly
95035821,9503582,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,201211.0,20121213.0,20130130,20130130,PER,US201212004576,ELI LILLY AND CO,55.0,YR,M,N,108.8,KG,20130104.0,,MD,US,,2013,Q1,Adult
95035981,9503598,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,,20121221.0,20130130,20130130,PER,US201212007505,ELI LILLY AND CO,50.0,YR,M,N,,,20130104.0,,MD,US,,2013,Q1,Adult
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Blood glucose decreased,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Blood glucose increased,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Injection site discomfort,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Malaise,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Nausea,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Tendon injury,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Urinary tract infection,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95036361,9503636,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D,,,,5,UG,,BID,2013,Q1,Weight increased,2013,Q1,1,I,2007.0,20121113.0,20130130,20130130,PER,US201211004174,ELI LILLY AND CO,68.0,YR,F,N,63.9,KG,20130104.0,,CN,US,,2013,Q1,Elderly
95037241,9503724,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q1,Pancreatitis,2013,Q1,1,I,201210.0,20121127.0,20130130,20130130,PER,US201211008676,ELI LILLY AND CO,52.0,YR,F,N,,,20130104.0,,MD,US,,2013,Q1,Adult
95056051,9505605,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Blood glucose increased,2013,Q1,1,I,,20120302.0,20130221,20130221,PER,1203USA00238,MERCK,59.0,YR,M,N,111.1,KG,20130121.0,,,US,,2013,Q1,Adult
95056051,9505605,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Pneumonia,2013,Q1,1,I,,20120302.0,20130221,20130221,PER,1203USA00238,MERCK,59.0,YR,M,N,111.1,KG,20130121.0,,,US,,2013,Q1,Adult
95056051,9505605,13,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Protein urine present,2013,Q1,1,I,,20120302.0,20130221,20130221,PER,1203USA00238,MERCK,59.0,YR,M,N,111.1,KG,20130121.0,,,US,,2013,Q1,Adult
95247131,9524713,10,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q1,Thrombosis,2013,Q1,1,I,20120216.0,20120606.0,20130305,20130305,PER,163-21880-12021863,CELGENE,69.0,YR,F,N,,,20120606.0,,MD,US,,2013,Q1,Elderly
65339602,6533960,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Chronic obstructive pulmonary disease,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Drug effect incomplete,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Gait disturbance,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Skin mass,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Chronic obstructive pulmonary disease,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Drug effect incomplete,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Gait disturbance,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Skin mass,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
65339602,6533960,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,2,F,200708.0,20130530.0,20071130,20130604,EXP,US200709001622,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,72.56,KG,20130604.0,,CN,US,US,2013,Q2,Elderly
67498452,6749845,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Lymphoma,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pruritus,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Rash,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Urticaria,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Lymphoma,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pruritus,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Rash,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
67498452,6749845,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Urticaria,2013,Q2,2,F,2008.0,20130508.0,20080731,20130517,EXP,US200806001501,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,79.36,KG,20130517.0,,CN,US,US,2013,Q2,Adult
80280802,8028080,2,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,ALOPECIA,2013,Q2,2,F,20081218.0,20121008.0,20110527,20130130,PER,US200901001583,ELI LILLY AND CO,65.0,YR,F,N,94.3,KG,20130104.0,,MD,US,,2013,Q2,Elderly
80280802,8028080,2,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,OFF LABEL USE,2013,Q2,2,F,20081218.0,20121008.0,20110527,20130130,PER,US200901001583,ELI LILLY AND CO,65.0,YR,F,N,94.3,KG,20130104.0,,MD,US,,2013,Q2,Elderly
80280802,8028080,2,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,PANCREATITIS ACUTE,2013,Q2,2,F,20081218.0,20121008.0,20110527,20130130,PER,US200901001583,ELI LILLY AND CO,65.0,YR,F,N,94.3,KG,20130104.0,,MD,US,,2013,Q2,Elderly
80280802,8028080,2,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,Pancreatitis,2013,Q2,2,F,20081218.0,20121008.0,20110527,20130130,PER,US200901001583,ELI LILLY AND CO,65.0,YR,F,N,94.3,KG,20130104.0,,MD,US,,2013,Q2,Elderly
80280802,8028080,2,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,Renal failure acute,2013,Q2,2,F,20081218.0,20121008.0,20110527,20130130,PER,US200901001583,ELI LILLY AND CO,65.0,YR,F,N,94.3,KG,20130104.0,,MD,US,,2013,Q2,Elderly
80280802,8028080,2,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,WEIGHT DECREASED,2013,Q2,2,F,20081218.0,20121008.0,20110527,20130130,PER,US200901001583,ELI LILLY AND CO,65.0,YR,F,N,94.3,KG,20130104.0,,MD,US,,2013,Q2,Elderly
80280852,8028085,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis,2013,Q2,2,F,200901.0,20130411.0,20110527,20130423,EXP,US200902002442,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,64.85,KG,20130423.0,,CN,US,US,2013,Q2,Elderly
80280852,8028085,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Renal injury,2013,Q2,2,F,200901.0,20130411.0,20110527,20130423,EXP,US200902002442,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,64.85,KG,20130423.0,,CN,US,US,2013,Q2,Elderly
80280852,8028085,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,2,F,200901.0,20130411.0,20110527,20130423,EXP,US200902002442,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,64.85,KG,20130423.0,,CN,US,US,2013,Q2,Elderly
81849706,8184970,3,SS,EXENATIDE,1,UNKNOWN,"DOSE INCREASED TO 10UG, 2X/DAY AFTER FOUR HOURS.?10MCG,2 IN 1 DAY?5MCG ,2 IN 1 DAY10 MCG 2 IN 1 D",,,,D,,,,5,UG,,BID,2013,Q2,Body mass index decreased,2013,Q2,6,F,,20130328.0,20111018,20130409,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-16145534,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,,,20130409.0,,CN,DE,GB,2013,Q2,Adult
81849706,8184970,3,SS,EXENATIDE,1,UNKNOWN,"DOSE INCREASED TO 10UG, 2X/DAY AFTER FOUR HOURS.?10MCG,2 IN 1 DAY?5MCG ,2 IN 1 DAY10 MCG 2 IN 1 D",,,,D,,,,5,UG,,BID,2013,Q2,Gastrointestinal disorder,2013,Q2,6,F,,20130328.0,20111018,20130409,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-16145534,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,,,20130409.0,,CN,DE,GB,2013,Q2,Adult
81849706,8184970,3,SS,EXENATIDE,1,UNKNOWN,"DOSE INCREASED TO 10UG, 2X/DAY AFTER FOUR HOURS.?10MCG,2 IN 1 DAY?5MCG ,2 IN 1 DAY10 MCG 2 IN 1 D",,,,D,,,,5,UG,,BID,2013,Q2,Malaise,2013,Q2,6,F,,20130328.0,20111018,20130409,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-16145534,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,,,20130409.0,,CN,DE,GB,2013,Q2,Adult
81849706,8184970,3,SS,EXENATIDE,1,UNKNOWN,"DOSE INCREASED TO 10UG, 2X/DAY AFTER FOUR HOURS.?10MCG,2 IN 1 DAY?5MCG ,2 IN 1 DAY10 MCG 2 IN 1 D",,,,D,,,,5,UG,,BID,2013,Q2,Off label use,2013,Q2,6,F,,20130328.0,20111018,20130409,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-16145534,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,,,20130409.0,,CN,DE,GB,2013,Q2,Adult
81849706,8184970,3,SS,EXENATIDE,1,UNKNOWN,"DOSE INCREASED TO 10UG, 2X/DAY AFTER FOUR HOURS.?10MCG,2 IN 1 DAY?5MCG ,2 IN 1 DAY10 MCG 2 IN 1 D",,,,D,,,,5,UG,,BID,2013,Q2,Potentiating drug interaction,2013,Q2,6,F,,20130328.0,20111018,20130409,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-16145534,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,,,20130409.0,,CN,DE,GB,2013,Q2,Adult
81849706,8184970,3,SS,EXENATIDE,1,UNKNOWN,"DOSE INCREASED TO 10UG, 2X/DAY AFTER FOUR HOURS.?10MCG,2 IN 1 DAY?5MCG ,2 IN 1 DAY10 MCG 2 IN 1 D",,,,D,,,,5,UG,,BID,2013,Q2,Renal failure acute,2013,Q2,6,F,,20130328.0,20111018,20130409,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-16145534,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,,,20130409.0,,CN,DE,GB,2013,Q2,Adult
83343862,8334386,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis acute,2013,Q2,2,F,200701.0,20130416.0,20111130,20130426,EXP,US200906001549,BRISTOL MYERS SQUIBB,65.0,YR,M,Y,103.86,KG,20130426.0,,CN,US,US,2013,Q2,Elderly
83343862,8334386,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis relapsing,2013,Q2,2,F,200701.0,20130416.0,20111130,20130426,EXP,US200906001549,BRISTOL MYERS SQUIBB,65.0,YR,M,Y,103.86,KG,20130426.0,,CN,US,US,2013,Q2,Elderly
87619144,8761914,17,C,EXENATIDE,1,,,,,,D,,,,10,MG,,,2013,Q2,Haematuria,2013,Q2,4,F,20120807.0,20130416.0,20120830,20130419,EXP,US-JNJFOC-20120813826,JANSSEN,78.0,YR,M,Y,,,20130419.0,,MD,US,US,2013,Q2,Elderly
87619144,8761914,17,C,EXENATIDE,1,,,,,,D,,,,10,MG,,,2013,Q2,Renal failure acute,2013,Q2,4,F,20120807.0,20130416.0,20120830,20130419,EXP,US-JNJFOC-20120813826,JANSSEN,78.0,YR,M,Y,,,20130419.0,,MD,US,US,2013,Q2,Elderly
89246322,8924632,2,SS,EXENATIDE 2MG VIAL + SYRINGE,1,SUBCUTANEOUS,,,,,U,,,,2,MG,INJECTION,/wk,2013,Q2,Constipation,2013,Q2,2,F,201208.0,20130327.0,20121126,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-16962946,BRISTOL MYERS SQUIBB,66.0,YR,M,Y,104.31,KG,20130525.0,,OT,US,US,2013,Q2,Elderly
89246322,8924632,2,SS,EXENATIDE 2MG VIAL + SYRINGE,1,SUBCUTANEOUS,,,,,U,,,,2,MG,INJECTION,/wk,2013,Q2,Gastrooesophageal reflux disease,2013,Q2,2,F,201208.0,20130327.0,20121126,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-16962946,BRISTOL MYERS SQUIBB,66.0,YR,M,Y,104.31,KG,20130525.0,,OT,US,US,2013,Q2,Elderly
91638892,9163889,2,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Body mass index increased,2013,Q2,2,F,,20130612.0,20130314,20130621,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303001235,ELI LILLY AND CO,43.0,YR,F,Y,101.0,KG,20130621.0,,MD,GB,GB,2013,Q2,Adult
91638892,9163889,2,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Dyspnoea,2013,Q2,2,F,,20130612.0,20130314,20130621,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303001235,ELI LILLY AND CO,43.0,YR,F,Y,101.0,KG,20130621.0,,MD,GB,GB,2013,Q2,Adult
91638892,9163889,2,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Mobility decreased,2013,Q2,2,F,,20130612.0,20130314,20130621,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303001235,ELI LILLY AND CO,43.0,YR,F,Y,101.0,KG,20130621.0,,MD,GB,GB,2013,Q2,Adult
91638892,9163889,2,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Musculoskeletal pain,2013,Q2,2,F,,20130612.0,20130314,20130621,EXP,GB-ELI_LILLY_AND_COMPANY-GB201303001235,ELI LILLY AND CO,43.0,YR,F,Y,101.0,KG,20130621.0,,MD,GB,GB,2013,Q2,Adult
91768012,9176801,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Convulsion,2013,Q2,2,F,,20130514.0,20120531,20130529,EXP,US201201007361,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,,,20130529.0,,MD,US,US,2013,Q2,Adult
91768012,9176801,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Diabetic ketoacidosis,2013,Q2,2,F,,20130514.0,20120531,20130529,EXP,US201201007361,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,,,20130529.0,,MD,US,US,2013,Q2,Adult
91768012,9176801,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis acute,2013,Q2,2,F,,20130514.0,20120531,20130529,EXP,US201201007361,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,,,20130529.0,,MD,US,US,2013,Q2,Adult
91768012,9176801,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Renal failure acute,2013,Q2,2,F,,20130514.0,20120531,20130529,EXP,US201201007361,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,,,20130529.0,,MD,US,US,2013,Q2,Adult
91768012,9176801,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Respiratory failure,2013,Q2,2,F,,20130514.0,20120531,20130529,EXP,US201201007361,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,,,20130529.0,,MD,US,US,2013,Q2,Adult
91774982,9177498,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,5,UG,,BID,2013,Q2,Pancreatitis,2013,Q2,2,F,,20121022.0,20120531,20130130,PER,US201201007483,ELI LILLY AND CO,73.0,YR,M,N,,,20120104.0,,LW,US,,2013,Q2,Elderly
91774982,9177498,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,5,UG,,BID,2013,Q2,Renal failure,2013,Q2,2,F,,20121022.0,20120531,20130130,PER,US201201007483,ELI LILLY AND CO,73.0,YR,M,N,,,20120104.0,,LW,US,,2013,Q2,Elderly
91774982,9177498,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,,D,,,21773.0,5,UG,,BID,2013,Q2,Renal failure chronic,2013,Q2,2,F,,20121022.0,20120531,20130130,PER,US201201007483,ELI LILLY AND CO,73.0,YR,M,N,,,20120104.0,,LW,US,,2013,Q2,Elderly
91777362,9177736,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,,D,,,21773.0,10,UG,,,2013,Q2,Pancreatitis acute,2013,Q2,2,F,,20121217.0,20120531,20130130,PER,US201201007404,ELI LILLY AND CO,63.0,YR,M,N,,,20130104.0,,LW,US,,2013,Q2,Adult
91810072,9181007,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,,,,,21773.0,,,,,2013,Q2,Pancreatitis acute,2013,Q2,2,F,,20121025.0,20120531,20130130,PER,US201201008022,ELI LILLY AND CO,55.0,YR,M,N,,,20120104.0,,LW,US,,2013,Q2,Adult
92020031,9202003,1,PS,EXENATIDE,1,SUBCUTANEOUS,"5 UG, BID",,,,D,,,21773.0,5,UG,INJECTION,BID,2013,Q2,Cholecystitis,2013,Q2,1,I,20120209.0,20130329.0,20130401,20130401,EXP,JP-ELI_LILLY_AND_COMPANY-JP201203005018,ELI LILLY AND CO,58.0,YR,M,Y,106.0,KG,20130331.0,,CN,JP,JP,2013,Q2,Adult
92020031,9202003,1,PS,EXENATIDE,1,SUBCUTANEOUS,"5 UG, BID",,,,D,,,21773.0,5,UG,INJECTION,BID,2013,Q2,Cholelithiasis,2013,Q2,1,I,20120209.0,20130329.0,20130401,20130401,EXP,JP-ELI_LILLY_AND_COMPANY-JP201203005018,ELI LILLY AND CO,58.0,YR,M,Y,106.0,KG,20130331.0,,CN,JP,JP,2013,Q2,Adult
92020031,9202003,2,SS,EXENATIDE,1,SUBCUTANEOUS,"10 UG, BID",,,,D,,,21773.0,10,UG,INJECTION,BID,2013,Q2,Cholecystitis,2013,Q2,1,I,20120209.0,20130329.0,20130401,20130401,EXP,JP-ELI_LILLY_AND_COMPANY-JP201203005018,ELI LILLY AND CO,58.0,YR,M,Y,106.0,KG,20130331.0,,CN,JP,JP,2013,Q2,Adult
92020031,9202003,2,SS,EXENATIDE,1,SUBCUTANEOUS,"10 UG, BID",,,,D,,,21773.0,10,UG,INJECTION,BID,2013,Q2,Cholelithiasis,2013,Q2,1,I,20120209.0,20130329.0,20130401,20130401,EXP,JP-ELI_LILLY_AND_COMPANY-JP201203005018,ELI LILLY AND CO,58.0,YR,M,Y,106.0,KG,20130331.0,,CN,JP,JP,2013,Q2,Adult
92052491,9205249,1,PS,EXENATIDE,1,SUBCUTANEOUS,"9 MG, OTHER",,,,D,,,22200.0,9,MG,,,2013,Q2,Cardiac arrest,2013,Q2,1,I,20130327.0,20130328.0,20130402,20130402,EXP,US-ELI_LILLY_AND_COMPANY-US201303010149,ELI LILLY AND CO,38.0,YR,M,Y,,,20130402.0,,MD,US,US,2013,Q2,Adult
92052491,9205249,1,PS,EXENATIDE,1,SUBCUTANEOUS,"9 MG, OTHER",,,,D,,,22200.0,9,MG,,,2013,Q2,Fall,2013,Q2,1,I,20130327.0,20130328.0,20130402,20130402,EXP,US-ELI_LILLY_AND_COMPANY-US201303010149,ELI LILLY AND CO,38.0,YR,M,Y,,,20130402.0,,MD,US,US,2013,Q2,Adult
92052491,9205249,1,PS,EXENATIDE,1,SUBCUTANEOUS,"9 MG, OTHER",,,,D,,,22200.0,9,MG,,,2013,Q2,Nausea,2013,Q2,1,I,20130327.0,20130328.0,20130402,20130402,EXP,US-ELI_LILLY_AND_COMPANY-US201303010149,ELI LILLY AND CO,38.0,YR,M,Y,,,20130402.0,,MD,US,US,2013,Q2,Adult
92052491,9205249,1,PS,EXENATIDE,1,SUBCUTANEOUS,"9 MG, OTHER",,,,D,,,22200.0,9,MG,,,2013,Q2,Pneumonia,2013,Q2,1,I,20130327.0,20130328.0,20130402,20130402,EXP,US-ELI_LILLY_AND_COMPANY-US201303010149,ELI LILLY AND CO,38.0,YR,M,Y,,,20130402.0,,MD,US,US,2013,Q2,Adult
92052491,9205249,1,PS,EXENATIDE,1,SUBCUTANEOUS,"9 MG, OTHER",,,,D,,,22200.0,9,MG,,,2013,Q2,Vomiting,2013,Q2,1,I,20130327.0,20130328.0,20130402,20130402,EXP,US-ELI_LILLY_AND_COMPANY-US201303010149,ELI LILLY AND CO,38.0,YR,M,Y,,,20130402.0,,MD,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Asthenia,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Constipation,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dizziness,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Fall,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site bruising,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Loss of consciousness,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92054111,9205411,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,,20130226.0,20130402,20130402,PER,US201211006791,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,83.9,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92058851,9205885,11,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Bladder cancer,2013,Q2,1,I,20091007.0,20130326.0,20130401,20130401,EXP,TPA2013A02416,TAKEDA,67.0,YR,M,N,200.0,LBS,20130329.0,,OT,US,,2013,Q2,Elderly
92060071,9206007,2,SS,EXENATIDE,1,SUBCUTANEOUS,5 MCG IN AM AND 10 MCG IN PM,,,,D, A902256D,,,,,,,2013,Q2,Arrhythmia,2013,Q2,1,I,,20130326.0,20130403,20130403,EXP,US-SANOFI-AVENTIS-2013SA033471,AVENTIS,63.0,YR,F,Y,77.8,KG,20130403.0,,MD,US,US,2013,Q2,Adult
92060071,9206007,2,SS,EXENATIDE,1,SUBCUTANEOUS,5 MCG IN AM AND 10 MCG IN PM,,,,D, A902256D,,,,,,,2013,Q2,Coronary artery disease,2013,Q2,1,I,,20130326.0,20130403,20130403,EXP,US-SANOFI-AVENTIS-2013SA033471,AVENTIS,63.0,YR,F,Y,77.8,KG,20130403.0,,MD,US,US,2013,Q2,Adult
92060071,9206007,2,SS,EXENATIDE,1,SUBCUTANEOUS,5 MCG IN AM AND 10 MCG IN PM,,,,D, A902256D,,,,,,,2013,Q2,Myocardial ischaemia,2013,Q2,1,I,,20130326.0,20130403,20130403,EXP,US-SANOFI-AVENTIS-2013SA033471,AVENTIS,63.0,YR,F,Y,77.8,KG,20130403.0,,MD,US,US,2013,Q2,Adult
92065532,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q2,Blood glucose decreased,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q2,Communication disorder,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q2,Underdose,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q2,Vision blurred,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,1,PS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,SUBCUTANEOUS,,,,D,D,,,21773.0,5,UG,,BID,2013,Q2,Weight decreased,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q2,Communication disorder,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q2,Underdose,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q2,Vision blurred,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92065532,9206553,3,C,"EXENATIDE 10MCG PEN , DISPOSABLE DEVICE (EXENATIDE PEN (10MCG)) PEN, DISPOSABLE",2,,,,,,,,,,,,,,2013,Q2,Weight decreased,2013,Q2,2,F,,20120416.0,20120731,20121130,PER,US201204005171,ELI LILLY AND CO,65.0,YR,F,N,81.6,KG,20121115.0,,CN,US,,2013,Q2,Elderly
92150901,9215090,5,C,EXENATIDE,1,,"1 DF, BID",,,,U,,,,1,DF,,BID,2013,Q2,Drug interaction,2013,Q2,1,I,20130304.0,20130404.0,20130405,20130405,EXP,PHHY2013GB032737,SANDOZ,66.0,YR,M,Y,,,20130405.0,,OT,GB,GB,2013,Q2,Elderly
92150901,9215090,5,C,EXENATIDE,1,,"1 DF, BID",,,,U,,,,1,DF,,BID,2013,Q2,Palpitations,2013,Q2,1,I,20130304.0,20130404.0,20130405,20130405,EXP,PHHY2013GB032737,SANDOZ,66.0,YR,M,Y,,,20130405.0,,OT,GB,GB,2013,Q2,Elderly
92178721,9217872,5,C,EXENATIDE,1,,"10 MG (1 DOSAGE FORM), 2X/DAY",,,,D,,,,10,MG,,BID,2013,Q2,Drug interaction,2013,Q2,1,I,20130304.0,20130404.0,20130408,20130408,EXP,GB-PFIZER INC-2013108068,PFIZER,66.0,YR,M,Y,,,20130408.0,,CN,GB,GB,2013,Q2,Elderly
92178721,9217872,5,C,EXENATIDE,1,,"10 MG (1 DOSAGE FORM), 2X/DAY",,,,D,,,,10,MG,,BID,2013,Q2,Palpitations,2013,Q2,1,I,20130304.0,20130404.0,20130408,20130408,EXP,GB-PFIZER INC-2013108068,PFIZER,66.0,YR,M,Y,,,20130408.0,,CN,GB,GB,2013,Q2,Elderly
92217321,9221732,6,C,EXENATIDE (EXENATIDE),1,,,,,,,,,,,,,,2013,Q2,Drug interaction,2013,Q2,1,I,20130304.0,20130403.0,20130408,20130408,EXP,GER/UKI/13/0028889,DR REDDYS,66.0,YR,M,N,,,20130405.0,,CN,GB,,2013,Q2,Elderly
92217321,9221732,6,C,EXENATIDE (EXENATIDE),1,,,,,,,,,,,,,,2013,Q2,Palpitations,2013,Q2,1,I,20130304.0,20130403.0,20130408,20130408,EXP,GER/UKI/13/0028889,DR REDDYS,66.0,YR,M,N,,,20130405.0,,CN,GB,,2013,Q2,Elderly
92234251,9223425,5,C,EXENATIDE,1,,20 MILLIGRAM DAILY;,,,,D,,,,10,MG,,BID,2013,Q2,Drug interaction,2013,Q2,1,I,20130304.0,20130404.0,20130410,20130410,EXP,GB-TEVA-396558ISR,TEVA,66.0,YR,M,Y,,,20130410.0,,CN,GB,GB,2013,Q2,Elderly
92234251,9223425,5,C,EXENATIDE,1,,20 MILLIGRAM DAILY;,,,,D,,,,10,MG,,BID,2013,Q2,Palpitations,2013,Q2,1,I,20130304.0,20130404.0,20130410,20130410,EXP,GB-TEVA-396558ISR,TEVA,66.0,YR,M,Y,,,20130410.0,,CN,GB,GB,2013,Q2,Elderly
92257781,9225778,18,C,EXENATIDE/BYETTA,2,,,,,,,,,,,,,,2013,Q2,Anaemia,2013,Q2,1,I,20130215.0,,20130410,20130410,DIR,,,82.0,YR,M,N,85.3,KG,20130219.0,,PH,US,,2013,Q2,Elderly
92257781,9225778,18,C,EXENATIDE/BYETTA,2,,,,,,,,,,,,,,2013,Q2,Asthenia,2013,Q2,1,I,20130215.0,,20130410,20130410,DIR,,,82.0,YR,M,N,85.3,KG,20130219.0,,PH,US,,2013,Q2,Elderly
92257781,9225778,18,C,EXENATIDE/BYETTA,2,,,,,,,,,,,,,,2013,Q2,Dizziness,2013,Q2,1,I,20130215.0,,20130410,20130410,DIR,,,82.0,YR,M,N,85.3,KG,20130219.0,,PH,US,,2013,Q2,Elderly
92257781,9225778,18,C,EXENATIDE/BYETTA,2,,,,,,,,,,,,,,2013,Q2,Gastric ulcer,2013,Q2,1,I,20130215.0,,20130410,20130410,DIR,,,82.0,YR,M,N,85.3,KG,20130219.0,,PH,US,,2013,Q2,Elderly
92257781,9225778,18,C,EXENATIDE/BYETTA,2,,,,,,,,,,,,,,2013,Q2,Intestinal ulcer,2013,Q2,1,I,20130215.0,,20130410,20130410,DIR,,,82.0,YR,M,N,85.3,KG,20130219.0,,PH,US,,2013,Q2,Elderly
92257781,9225778,18,C,EXENATIDE/BYETTA,2,,,,,,,,,,,,,,2013,Q2,Upper gastrointestinal haemorrhage,2013,Q2,1,I,20130215.0,,20130410,20130410,DIR,,,82.0,YR,M,N,85.3,KG,20130219.0,,PH,US,,2013,Q2,Elderly
92334741,9233474,10,C,EXENATIDE,1,,INJECTION,,,,D,,,,,,,/wk,2013,Q2,Lung disorder,2013,Q2,1,I,201212.0,20130405.0,20130416,20130416,EXP,NL-BRISTOL-MYERS SQUIBB COMPANY-18585828,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,,,20130416.0,,CN,US,NL,2013,Q2,Elderly
92348521,9234852,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Hyperlipidaemia,2013,Q2,1,I,20080602.0,20130401.0,20130416,20130416,EXP,US201001002934,BRISTOL MYERS SQUIBB,50.0,YR,M,Y,102.04,KG,20130416.0,,CN,US,US,2013,Q2,Adult
92348521,9234852,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20080602.0,20130401.0,20130416,20130416,EXP,US201001002934,BRISTOL MYERS SQUIBB,50.0,YR,M,Y,102.04,KG,20130416.0,,CN,US,US,2013,Q2,Adult
92348521,9234852,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis acute,2013,Q2,1,I,20080602.0,20130401.0,20130416,20130416,EXP,US201001002934,BRISTOL MYERS SQUIBB,50.0,YR,M,Y,102.04,KG,20130416.0,,CN,US,US,2013,Q2,Adult
92368431,9236843,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Hyperglycaemia,2013,Q2,1,I,201202.0,20130405.0,20130417,20130417,EXP,JP-BRISTOL-MYERS SQUIBB COMPANY-18562967,BRISTOL MYERS SQUIBB,61.0,YR,F,Y,,,20130417.0,,CN,JP,JP,2013,Q2,Adult
92368671,9236867,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Duodenal ulcer,2013,Q2,1,I,20061007.0,20130405.0,20130417,20130417,EXP,US200906004681,BRISTOL MYERS SQUIBB,77.0,YR,F,Y,68.03,KG,20130417.0,,CN,US,US,2013,Q2,Elderly
92368671,9236867,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20061007.0,20130405.0,20130417,20130417,EXP,US200906004681,BRISTOL MYERS SQUIBB,77.0,YR,F,Y,68.03,KG,20130417.0,,CN,US,US,2013,Q2,Elderly
92368671,9236867,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatic carcinoma metastatic,2013,Q2,1,I,20061007.0,20130405.0,20130417,20130417,EXP,US200906004681,BRISTOL MYERS SQUIBB,77.0,YR,F,Y,68.03,KG,20130417.0,,CN,US,US,2013,Q2,Elderly
92368671,9236867,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pyrexia,2013,Q2,1,I,20061007.0,20130405.0,20130417,20130417,EXP,US200906004681,BRISTOL MYERS SQUIBB,77.0,YR,F,Y,68.03,KG,20130417.0,,CN,US,US,2013,Q2,Elderly
92368671,9236867,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Renal injury,2013,Q2,1,I,20061007.0,20130405.0,20130417,20130417,EXP,US200906004681,BRISTOL MYERS SQUIBB,77.0,YR,F,Y,68.03,KG,20130417.0,,CN,US,US,2013,Q2,Elderly
92372681,9237268,3,C,EXENATIDE,1,,,,,,D,,,,1,DF,,BID,2013,Q2,Drug interaction,2013,Q2,1,I,20130304.0,20130404.0,20130417,20130417,EXP,GB-MYLANLABS-2013S1007520,MYLAN,66.0,YR,M,Y,,,20130417.0,,CN,GB,GB,2013,Q2,Elderly
92372681,9237268,3,C,EXENATIDE,1,,,,,,D,,,,1,DF,,BID,2013,Q2,Palpitations,2013,Q2,1,I,20130304.0,20130404.0,20130417,20130417,EXP,GB-MYLANLABS-2013S1007520,MYLAN,66.0,YR,M,Y,,,20130417.0,,CN,GB,GB,2013,Q2,Elderly
92375571,9237557,3,C,Exenatide,1,UNKNOWN,"1 DF, UNK",,,,D,,,,1,DF,,Q12H,2013,Q2,Drug interaction,2013,Q2,1,I,20130304.0,20130404.0,20130418,20130418,EXP,GB-RANBAXY-2013R1-67323,RANBAXY,66.0,YR,M,Y,,,20130418.0,,OT,GB,GB,2013,Q2,Elderly
92375571,9237557,3,C,Exenatide,1,UNKNOWN,"1 DF, UNK",,,,D,,,,1,DF,,Q12H,2013,Q2,Palpitations,2013,Q2,1,I,20130304.0,20130404.0,20130418,20130418,EXP,GB-RANBAXY-2013R1-67323,RANBAXY,66.0,YR,M,Y,,,20130418.0,,OT,GB,GB,2013,Q2,Elderly
92418111,9241811,2,I,Exenatide,1,UNKNOWN,"10 ?G, BID",,,,D,,,,10,UG,,Q12H,2013,Q2,Adrenal insufficiency,2013,Q2,1,I,,20130405.0,20130419,20130419,EXP,JP-RANBAXY-2013R1-67609,RANBAXY,50.0,YR,F,Y,,,20130419.0,,OT,JP,JP,2013,Q2,Adult
92418111,9241811,2,I,Exenatide,1,UNKNOWN,"10 ?G, BID",,,,D,,,,10,UG,,Q12H,2013,Q2,Drug interaction,2013,Q2,1,I,,20130405.0,20130419,20130419,EXP,JP-RANBAXY-2013R1-67609,RANBAXY,50.0,YR,F,Y,,,20130419.0,,OT,JP,JP,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Bladder cancer,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood pressure decreased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dry mouth,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Kidney infection,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Renal impairment,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,8,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Bladder cancer,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood pressure decreased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dry mouth,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Kidney infection,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Renal impairment,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92427931,9242793,9,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,20120312.0,20130409.0,20130419,20130419,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722603,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,138.32,KG,20130525.0,,CN,US,US,2013,Q2,Adult
92428941,9242894,2,SS,EXENATIDE,1,,,,,,D, UNKOWN,,,2,MG,,/wk,2013,Q2,Blood glucose fluctuation,2013,Q2,1,I,20130122.0,20130405.0,20130419,20130419,EXP,US-SANOFI-AVENTIS-2013SA040591,AVENTIS,71.0,YR,F,Y,,,20130523.0,,CN,US,US,2013,Q2,Elderly
92428941,9242894,2,SS,EXENATIDE,1,,,,,,D, UNKOWN,,,2,MG,,/wk,2013,Q2,Foot operation,2013,Q2,1,I,20130122.0,20130405.0,20130419,20130419,EXP,US-SANOFI-AVENTIS-2013SA040591,AVENTIS,71.0,YR,F,Y,,,20130523.0,,CN,US,US,2013,Q2,Elderly
92428941,9242894,2,SS,EXENATIDE,1,,,,,,D, UNKOWN,,,2,MG,,/wk,2013,Q2,Foreign body aspiration,2013,Q2,1,I,20130122.0,20130405.0,20130419,20130419,EXP,US-SANOFI-AVENTIS-2013SA040591,AVENTIS,71.0,YR,F,Y,,,20130523.0,,CN,US,US,2013,Q2,Elderly
92428941,9242894,2,SS,EXENATIDE,1,,,,,,D, UNKOWN,,,2,MG,,/wk,2013,Q2,Gastric haemorrhage,2013,Q2,1,I,20130122.0,20130405.0,20130419,20130419,EXP,US-SANOFI-AVENTIS-2013SA040591,AVENTIS,71.0,YR,F,Y,,,20130523.0,,CN,US,US,2013,Q2,Elderly
92428941,9242894,2,SS,EXENATIDE,1,,,,,,D, UNKOWN,,,2,MG,,/wk,2013,Q2,Haematemesis,2013,Q2,1,I,20130122.0,20130405.0,20130419,20130419,EXP,US-SANOFI-AVENTIS-2013SA040591,AVENTIS,71.0,YR,F,Y,,,20130523.0,,CN,US,US,2013,Q2,Elderly
92449682,9244968,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,D,D,,,,,,,,2013,Q2,Angioedema,2013,Q2,2,F,,20121121.0,20121130,20130130,PER,US201209005422,ELI LILLY AND CO,27.0,YR,F,N,,,20130104.0,,MD,US,,2013,Q2,Young Adult
92449682,9244968,2,SS,"BYETTA (EXENATIDE) PEN, DISPOSABLE",1,,,,,D,D,,,,,,,,2013,Q2,Pruritus,2013,Q2,2,F,,20121121.0,20121130,20130130,PER,US201209005422,ELI LILLY AND CO,27.0,YR,F,N,,,20130104.0,,MD,US,,2013,Q2,Young Adult
92464142,9246414,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Adenocarcinoma pancreas,2013,Q2,2,F,200605.0,20130423.0,20130422,20130505,EXP,US200910005599,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,,,20130505.0,,CN,US,US,2013,Q2,Elderly
92464142,9246414,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Hospitalisation,2013,Q2,2,F,200605.0,20130423.0,20130422,20130505,EXP,US200910005599,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,,,20130505.0,,CN,US,US,2013,Q2,Elderly
92464142,9246414,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,2,F,200605.0,20130423.0,20130422,20130505,EXP,US200910005599,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,,,20130505.0,,CN,US,US,2013,Q2,Elderly
92464142,9246414,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis acute,2013,Q2,2,F,200605.0,20130423.0,20130422,20130505,EXP,US200910005599,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,,,20130505.0,,CN,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Anaemia,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Aortic valve disease,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Cataract operation,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Constipation,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dysphagia,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Endodontic procedure,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Fatigue,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Gastrooesophageal reflux disease,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Hiatus hernia,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Hypoaesthesia,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site pain,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Myocardial infarction,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Ovarian cancer stage IV,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Sleep apnoea syndrome,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Syncope,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92479031,9247903,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Visual impairment,2013,Q2,1,I,20090211.0,20130411.0,20130423,20130423,EXP,US201012003194,BRISTOL MYERS SQUIBB,65.0,YR,F,Y,126.08,KG,20130423.0,,MD,US,US,2013,Q2,Elderly
92480071,9248007,4,SS,EXENATIDE,1,UNKNOWN,"1DF:1 INJECTION,LAST INJ ON 21MAR13",,,,D, UNKNOWN,,,1,DF,INJECTION,/wk,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130415.0,20130423,20130423,EXP,GB-SANOFI-AVENTIS-2013SA040164,AVENTIS,53.0,YR,F,Y,,,20130423.0,,OT,GB,GB,2013,Q2,Adult
92480071,9248007,4,SS,EXENATIDE,1,UNKNOWN,"1DF:1 INJECTION,LAST INJ ON 21MAR13",,,,D, UNKNOWN,,,1,DF,INJECTION,/wk,2013,Q2,Injection site mass,2013,Q2,1,I,,20130415.0,20130423,20130423,EXP,GB-SANOFI-AVENTIS-2013SA040164,AVENTIS,53.0,YR,F,Y,,,20130423.0,,OT,GB,GB,2013,Q2,Adult
92586371,9258637,26,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,Angioedema,2013,Q2,1,I,20121023.0,,20130425,20130425,DIR,,,59.0,YR,F,N,130.0,KG,20130424.0,,PH,US,,2013,Q2,Adult
92586371,9258637,26,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,Swollen tongue,2013,Q2,1,I,20121023.0,,20130425,20130425,DIR,,,59.0,YR,F,N,130.0,KG,20130424.0,,PH,US,,2013,Q2,Adult
92586371,9258637,26,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q2,Tachycardia,2013,Q2,1,I,20121023.0,,20130425,20130425,DIR,,,59.0,YR,F,N,130.0,KG,20130424.0,,PH,US,,2013,Q2,Adult
92589901,9258990,1,PS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Pancreatic enlargement,2013,Q2,1,I,,20130415.0,20130426,20130426,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18791483,BRISTOL MYERS SQUIBB,49.0,YR,F,Y,,,20130426.0,,OT,US,US,2013,Q2,Adult
92590771,9259077,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Chest pain,2013,Q2,1,I,200801.0,20130416.0,20130426,20130426,EXP,US200910005987,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,107.94,KG,20130426.0,,CN,US,US,2013,Q2,Adult
92590771,9259077,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,200801.0,20130416.0,20130426,20130426,EXP,US200910005987,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,107.94,KG,20130426.0,,CN,US,US,2013,Q2,Adult
92590771,9259077,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis acute,2013,Q2,1,I,200801.0,20130416.0,20130426,20130426,EXP,US200910005987,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,107.94,KG,20130426.0,,CN,US,US,2013,Q2,Adult
92590771,9259077,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis chronic,2013,Q2,1,I,200801.0,20130416.0,20130426,20130426,EXP,US200910005987,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,107.94,KG,20130426.0,,CN,US,US,2013,Q2,Adult
92595021,9259502,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood potassium increased,2013,Q2,1,I,200704.0,20130416.0,20130428,20130428,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-17508086,BRISTOL MYERS SQUIBB,58.0,YR,M,Y,121.09,KG,20130428.0,,LW,US,US,2013,Q2,Adult
92595021,9259502,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Renal impairment,2013,Q2,1,I,200704.0,20130416.0,20130428,20130428,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-17508086,BRISTOL MYERS SQUIBB,58.0,YR,M,Y,121.09,KG,20130428.0,,LW,US,US,2013,Q2,Adult
92595051,9259505,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,200709.0,20130416.0,20130428,20130428,EXP,US201001003865,BRISTOL MYERS SQUIBB,49.0,YR,F,Y,101.59,KG,20130428.0,,CN,US,US,2013,Q2,Adult
92595051,9259505,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis acute,2013,Q2,1,I,200709.0,20130416.0,20130428,20130428,EXP,US201001003865,BRISTOL MYERS SQUIBB,49.0,YR,F,Y,101.59,KG,20130428.0,,CN,US,US,2013,Q2,Adult
92595051,9259505,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pancreatitis relapsing,2013,Q2,1,I,200709.0,20130416.0,20130428,20130428,EXP,US201001003865,BRISTOL MYERS SQUIBB,49.0,YR,F,Y,101.59,KG,20130428.0,,CN,US,US,2013,Q2,Adult
92655722,9265572,2,SS,EXENATIDE,1,SUBCUTANEOUS,"1 DF, 1/WEEK",,,,U, UNCONFIRMED,,,1,DF,,/wk,2013,Q2,Blood glucose increased,2013,Q2,2,F,,20130527.0,20130501,20130610,EXP,GB-WATSON-2013-07220,WATSON,52.0,YR,F,Y,,,20130610.0,,OT,GB,GB,2013,Q2,Adult
92655722,9265572,2,SS,EXENATIDE,1,SUBCUTANEOUS,"1 DF, 1/WEEK",,,,U, UNCONFIRMED,,,1,DF,,/wk,2013,Q2,Injection site inflammation,2013,Q2,2,F,,20130527.0,20130501,20130610,EXP,GB-WATSON-2013-07220,WATSON,52.0,YR,F,Y,,,20130610.0,,OT,GB,GB,2013,Q2,Adult
92655722,9265572,2,SS,EXENATIDE,1,SUBCUTANEOUS,"1 DF, 1/WEEK",,,,U, UNCONFIRMED,,,1,DF,,/wk,2013,Q2,Injection site mass,2013,Q2,2,F,,20130527.0,20130501,20130610,EXP,GB-WATSON-2013-07220,WATSON,52.0,YR,F,Y,,,20130610.0,,OT,GB,GB,2013,Q2,Adult
92655722,9265572,2,SS,EXENATIDE,1,SUBCUTANEOUS,"1 DF, 1/WEEK",,,,U, UNCONFIRMED,,,1,DF,,/wk,2013,Q2,Injection site pruritus,2013,Q2,2,F,,20130527.0,20130501,20130610,EXP,GB-WATSON-2013-07220,WATSON,52.0,YR,F,Y,,,20130610.0,,OT,GB,GB,2013,Q2,Adult
92674171,9267417,2,SS,EXENATIDE,1,,"5 UG, 2X/DAY",,,,D,,,,5,UG,,BID,2013,Q2,Adrenal insufficiency,2013,Q2,1,I,,20130426.0,20130502,20130502,EXP,JP-PFIZER INC-2013130801,PFIZER,50.0,YR,F,Y,,,20130501.0,,MD,JP,JP,2013,Q2,Adult
92674171,9267417,3,SS,EXENATIDE,1,,"10 UG, 2X/DAY",,,,D,,,,10,UG,,BID,2013,Q2,Adrenal insufficiency,2013,Q2,1,I,,20130426.0,20130502,20130502,EXP,JP-PFIZER INC-2013130801,PFIZER,50.0,YR,F,Y,,,20130501.0,,MD,JP,JP,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Anaphylactic shock,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Blood creatinine increased,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Cardiac valve disease,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Cerebral haemorrhage,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Disorientation,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Dissociation,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Heart rate increased,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Inappropriate schedule of drug administration,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Malaise,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Myalgia,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Product substitution issue,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Reaction to drug excipients,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92765803,9276580,29,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Treatment noncompliance,2013,Q2,3,F,201010.0,20130513.0,20130501,20130528,EXP,AUR-APL-2013-03554,AUROBINDO,64.0,YR,F,N,74.83,KG,20130524.0,,MD,US,,2013,Q2,Adult
92869461,9286946,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Idiopathic thrombocytopenic purpura,2013,Q2,1,I,,20130502.0,20130508,20130508,EXP,TPA2013A03301,TAKEDA,60.0,YR,F,N,,,20130507.0,,RN,US,,2013,Q2,Adult
92879831,9287983,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q2,Burning sensation,2013,Q2,1,I,201107.0,20130503.0,20130514,20130514,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-18866335,BRISTOL MYERS SQUIBB,65.0,YR,M,Y,,,20130514.0,,CN,GB,GB,2013,Q2,Elderly
92879831,9287983,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q2,Paraesthesia,2013,Q2,1,I,201107.0,20130503.0,20130514,20130514,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-18866335,BRISTOL MYERS SQUIBB,65.0,YR,M,Y,,,20130514.0,,CN,GB,GB,2013,Q2,Elderly
92879831,9287983,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q2,Photosensitivity reaction,2013,Q2,1,I,201107.0,20130503.0,20130514,20130514,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-18866335,BRISTOL MYERS SQUIBB,65.0,YR,M,Y,,,20130514.0,,CN,GB,GB,2013,Q2,Elderly
92879831,9287983,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q2,Rash erythematous,2013,Q2,1,I,201107.0,20130503.0,20130514,20130514,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-18866335,BRISTOL MYERS SQUIBB,65.0,YR,M,Y,,,20130514.0,,CN,GB,GB,2013,Q2,Elderly
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Anorgasmia,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Blood glucose abnormal,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Condition aggravated,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Erectile dysfunction,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Hand-arm vibration syndrome,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Lethargy,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Loss of libido,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92961271,9296127,6,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Paraesthesia,2013,Q2,1,I,2003.0,20130510.0,20130514,20130514,EXP,GER/UKI/13/0029517,DR REDDYS,54.0,YR,M,N,83.0,KG,20130513.0,,CN,GB,,2013,Q2,Adult
92994051,9299405,6,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Dyspepsia,2013,Q2,1,I,20130228.0,20130508.0,20130520,20130520,EXP,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2013-UK-01080UK",BOEHRINGER INGELHEIM,66.0,YR,F,Y,119.8,KG,20130521.0,,PH,GB,GB,2013,Q2,Elderly
92994051,9299405,6,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Dysphagia,2013,Q2,1,I,20130228.0,20130508.0,20130520,20130520,EXP,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2013-UK-01080UK",BOEHRINGER INGELHEIM,66.0,YR,F,Y,119.8,KG,20130521.0,,PH,GB,GB,2013,Q2,Elderly
93090921,9309092,15,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201302.0,20130311.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18714576,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,144.67,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93090921,9309092,15,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Cellulitis,2013,Q2,1,I,201302.0,20130311.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18714576,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,144.67,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93090921,9309092,15,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,201302.0,20130311.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18714576,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,144.67,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Back pain,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Headache,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Intentional drug misuse,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Malaise,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93090961,9309096,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,1,I,20130314.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722413,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Abdominal pain,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dysgeusia,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Headache,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Influenza,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site discolouration,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site induration,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pyrexia,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091031,9309103,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,,20130314.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18722702,BRISTOL MYERS SQUIBB,60.0,YR,M,Y,102.04,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93091151,9309115,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130310.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18723049,BRISTOL MYERS SQUIBB,55.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091151,9309115,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20130310.0,20130319.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18723049,BRISTOL MYERS SQUIBB,55.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091381,9309138,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18723551,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93091381,9309138,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18723551,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93091381,9309138,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dizziness,2013,Q2,1,I,,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18723551,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93091381,9309138,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18723551,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93091481,9309148,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18727248,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091481,9309148,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Drug dose omission,2013,Q2,1,I,,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18727248,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091481,9309148,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18727248,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091481,9309148,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site pain,2013,Q2,1,I,,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18727248,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091481,9309148,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18727248,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091631,9309163,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,2010.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577437,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091631,9309163,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,2010.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577437,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93091651,9309165,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130305.0,20130305.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18697516,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93091651,9309165,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20130305.0,20130305.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18697516,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Atrial fibrillation,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Atrial fibrillation,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Atrial fibrillation,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091711,9309171,7,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2009.0,20130103.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18577460,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,79.37,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93091961,9309196,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130124.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18583070,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092031,9309203,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,,20130113.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18580282,BRISTOL MYERS SQUIBB,73.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092031,9309203,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Headache,2013,Q2,1,I,,20130113.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18580282,BRISTOL MYERS SQUIBB,73.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092031,9309203,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Hunger,2013,Q2,1,I,,20130113.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18580282,BRISTOL MYERS SQUIBB,73.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092031,9309203,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,,20130113.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18580282,BRISTOL MYERS SQUIBB,73.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092031,9309203,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,,20130113.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18580282,BRISTOL MYERS SQUIBB,73.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092181,9309218,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2009.0,20130104.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578021,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092181,9309218,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,2009.0,20130104.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578021,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092181,9309218,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Injection site bruising,2013,Q2,1,I,2009.0,20130104.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578021,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092181,9309218,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,2009.0,20130104.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578021,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092231,9309223,3,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201212.0,20130114.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18580449,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93092251,9309225,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2010.0,20130106.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578062,BRISTOL MYERS SQUIBB,52.0,YR,M,Y,87.53,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93092251,9309225,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Muscle injury,2013,Q2,1,I,2010.0,20130106.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578062,BRISTOL MYERS SQUIBB,52.0,YR,M,Y,87.53,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93092251,9309225,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2010.0,20130106.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578062,BRISTOL MYERS SQUIBB,52.0,YR,M,Y,87.53,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93092291,9309229,2,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose abnormal,2013,Q2,1,I,,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578385,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092291,9309229,2,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578385,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092541,9309254,2,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20121231.0,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578633,BRISTOL MYERS SQUIBB,75.0,YR,F,Y,,,20130525.0,,PH,US,US,2013,Q2,Elderly
93092561,9309256,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose abnormal,2013,Q2,1,I,,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578658,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092561,9309256,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578658,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092601,9309260,2,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578674,BRISTOL MYERS SQUIBB,48.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092601,9309260,2,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,,20130107.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578674,BRISTOL MYERS SQUIBB,48.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092632,9309263,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,2,F,20130108.0,20130128.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578872,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092632,9309263,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Gastrointestinal sounds abnormal,2013,Q2,2,F,20130108.0,20130128.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18578872,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93092781,9309278,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Asthenia,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Hyperhidrosis,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Incorrect dose administered,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,4,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Asthenia,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,4,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,4,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,4,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Hyperhidrosis,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,4,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Incorrect dose administered,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,4,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,5,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Asthenia,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,5,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,5,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,5,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Hyperhidrosis,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,5,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Incorrect dose administered,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93092781,9309278,5,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20130108.0,20130108.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579086,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,90.7,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93093021,9309302,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581538,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093021,9309302,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581538,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093071,9309307,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,201107.0,20130109.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579409,BRISTOL MYERS SQUIBB,56.0,YR,M,Y,115.19,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093181,9309318,2,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130107.0,20130109.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579433,BRISTOL MYERS SQUIBB,70.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93093181,9309318,2,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,20130107.0,20130109.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18579433,BRISTOL MYERS SQUIBB,70.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93093271,9309327,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130216.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18697268,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093291,9309329,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201209.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581710,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093291,9309329,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Constipation,2013,Q2,1,I,201209.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581710,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093291,9309329,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,201209.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581710,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093291,9309329,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,201209.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581710,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093291,9309329,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201209.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581710,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093291,9309329,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,201209.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581710,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Abdominal pain,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Early satiety,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Feeling cold,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Feeling hot,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Gastrooesophageal reflux disease,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Hunger,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093321,9309332,3,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,20121129.0,20130117.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18581736,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93093561,9309356,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,201211.0,20130322.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728097,BRISTOL MYERS SQUIBB,59.0,YR,M,Y,98.87,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93095191,9309519,5,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201210.0,20130128.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584219,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,68.03,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93095191,9309519,5,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201210.0,20130128.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584219,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,68.03,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93095191,9309519,5,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,1,I,201210.0,20130128.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584219,BRISTOL MYERS SQUIBB,62.0,YR,F,Y,68.03,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Cardiac flutter,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Diverticulitis,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Flank pain,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Gastroenteritis viral,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Gastrooesophageal reflux disease,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Nervousness,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Urinary incontinence,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,4,SS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Cardiac flutter,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Diverticulitis,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Flank pain,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Gastroenteritis viral,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Gastrooesophageal reflux disease,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nervousness,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Urinary incontinence,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095231,9309523,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,20130122.0,20130129.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18584250,BRISTOL MYERS SQUIBB,76.0,YR,F,Y,74.83,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Asthenia,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Constipation,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Defaecation urgency,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dizziness,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Fatigue,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Feeling drunk,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Hypophagia,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Malaise,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Muscular weakness,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Overdose,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93095651,9309565,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,201202.0,20130320.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-17462706,BRISTOL MYERS SQUIBB,80.0,YR,M,Y,77.55,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Fatigue,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Flatulence,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,4,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Fatigue,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Flatulence,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096171,9309617,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,201206.0,20130201.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585554,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,95.24,KG,20130525.0,,CN,US,US,2013,Q2,Elderly
93096321,9309632,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,,20130325.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585794,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096321,9309632,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130325.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585794,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096321,9309632,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,,20130325.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585794,BRISTOL MYERS SQUIBB,67.0,YR,M,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096341,9309634,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201301.0,20130203.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585810,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93096341,9309634,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Hot flush,2013,Q2,1,I,201301.0,20130203.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585810,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93096341,9309634,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Hyperhidrosis,2013,Q2,1,I,201301.0,20130203.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18585810,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93096701,9309670,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Head discomfort,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site mass,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Head discomfort,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096701,9309670,6,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site mass,2013,Q2,1,I,201302.0,20130304.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586412,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096791,9309679,5,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130316.0,20130323.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18732487,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096791,9309679,5,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,20130316.0,20130323.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18732487,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096791,9309679,5,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dry mouth,2013,Q2,1,I,20130316.0,20130323.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18732487,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096791,9309679,5,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20130316.0,20130323.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18732487,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096791,9309679,5,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Pollakiuria,2013,Q2,1,I,20130316.0,20130323.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18732487,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93096791,9309679,5,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,20130316.0,20130323.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18732487,BRISTOL MYERS SQUIBB,68.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93097162,9309716,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,2,F,20121203.0,20130114.0,20130525,20130525,PER,US201212002279,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,63.49,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097162,9309716,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,2,F,20121203.0,20130114.0,20130525,20130525,PER,US201212002279,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,63.49,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097162,9309716,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Injection site nodule,2013,Q2,2,F,20121203.0,20130114.0,20130525,20130525,PER,US201212002279,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,63.49,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097162,9309716,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,2,F,20121203.0,20130114.0,20130525,20130525,PER,US201212002279,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,63.49,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Inappropriate schedule of drug administration,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Migraine,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Uterine cancer,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Inappropriate schedule of drug administration,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Migraine,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097241,9309724,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Uterine cancer,2013,Q2,1,I,201303.0,20130318.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18735746,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,87.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097391,9309739,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20130201.0,20130207.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586982,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93097391,9309739,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,1,I,20130201.0,20130207.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586982,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93097391,9309739,3,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,20130201.0,20130207.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18586982,BRISTOL MYERS SQUIBB,64.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93097501,9309750,3,SS,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201301.0,20130207.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18587055,BRISTOL MYERS SQUIBB,61.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dysphagia,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Eructation,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Sensation of foreign body,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dysphagia,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Eructation,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Sensation of foreign body,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93097961,9309796,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,,20130226.0,20130525,20130525,PER,US201109003384,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,86.62,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098101,9309810,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2011.0,20130208.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18587618,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93098101,9309810,4,SS,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,2011.0,20130208.0,20130525,20130525,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18587618,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Elderly
93098171,9309817,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,201206.0,20130307.0,20130525,20130525,PER,US201208000242,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93098171,9309817,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood iron decreased,2013,Q2,1,I,201206.0,20130307.0,20130525,20130525,PER,US201208000242,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93098171,9309817,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,201206.0,20130307.0,20130525,20130525,PER,US201208000242,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93098171,9309817,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Dizziness,2013,Q2,1,I,201206.0,20130307.0,20130525,20130525,PER,US201208000242,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93098171,9309817,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Migraine,2013,Q2,1,I,201206.0,20130307.0,20130525,20130525,PER,US201208000242,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93098171,9309817,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,201206.0,20130307.0,20130525,20130525,PER,US201208000242,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,,,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Protein urine present,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098292,9309829,5,SS,"EXENATIDE 5MCG PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,2,F,20120919.0,20130125.0,20130525,20130525,PER,US201209007799,BRISTOL MYERS SQUIBB,60.0,YR,F,Y,126.08,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Eating disorder symptom,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Headache,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Increased appetite,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site pain,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Sleep disorder,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Eating disorder symptom,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Glycosylated haemoglobin increased,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Headache,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Increased appetite,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site haemorrhage,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Injection site pain,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Nausea,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Sleep disorder,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93098311,9309831,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2011.0,20130302.0,20130525,20130525,PER,US201210000197,BRISTOL MYERS SQUIBB,51.0,YR,F,Y,81.63,KG,20130525.0,,CN,US,US,2013,Q2,Adult
93115971,9311597,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,20120805.0,20130517.0,20130528,20130528,EXP,US201208004967,BRISTOL MYERS SQUIBB,79.0,YR,M,Y,,,20130528.0,,CN,US,US,2013,Q2,Elderly
93115971,9311597,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Drug ineffective,2013,Q2,1,I,20120805.0,20130517.0,20130528,20130528,EXP,US201208004967,BRISTOL MYERS SQUIBB,79.0,YR,M,Y,,,20130528.0,,CN,US,US,2013,Q2,Elderly
93115971,9311597,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",2,,,,,,D,,,,,,,,2013,Q2,Product quality issue,2013,Q2,1,I,20120805.0,20130517.0,20130528,20130528,EXP,US201208004967,BRISTOL MYERS SQUIBB,79.0,YR,M,Y,,,20130528.0,,CN,US,US,2013,Q2,Elderly
93140581,9314058,1,PS,EXENATIDE,1,,,,,Y,D,,,,10,UG,,BID,2013,Q2,Pancreatitis,2013,Q2,1,I,20130305.0,,20130524,20130524,DIR,,,52.0,YR,M,N,,,,,PH,US,,2013,Q2,Adult
93140581,9314058,1,PS,EXENATIDE,1,,,,,Y,D,,,,10,UG,,BID,2013,Q2,Pancreatitis acute,2013,Q2,1,I,20130305.0,,20130524,20130524,DIR,,,52.0,YR,M,N,,,,,PH,US,,2013,Q2,Adult
93140581,9314058,1,PS,EXENATIDE,1,,,,,Y,D,,,,10,UG,,BID,2013,Q2,Pancreatitis necrotising,2013,Q2,1,I,20130305.0,,20130524,20130524,DIR,,,52.0,YR,M,N,,,,,PH,US,,2013,Q2,Adult
93140581,9314058,1,PS,EXENATIDE,1,,,,,Y,D,,,,10,UG,,BID,2013,Q2,Pulmonary oedema,2013,Q2,1,I,20130305.0,,20130524,20130524,DIR,,,52.0,YR,M,N,,,,,PH,US,,2013,Q2,Adult
93140581,9314058,1,PS,EXENATIDE,1,,,,,Y,D,,,,10,UG,,BID,2013,Q2,Renal failure acute,2013,Q2,1,I,20130305.0,,20130524,20130524,DIR,,,52.0,YR,M,N,,,,,PH,US,,2013,Q2,Adult
93140581,9314058,1,PS,EXENATIDE,1,,,,,Y,D,,,,10,UG,,BID,2013,Q2,Systemic inflammatory response syndrome,2013,Q2,1,I,20130305.0,,20130524,20130524,DIR,,,52.0,YR,M,N,,,,,PH,US,,2013,Q2,Adult
93146761,9314676,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis chronic,2013,Q2,1,I,20090325.0,20130514.0,20130529,20130529,EXP,US201002003426,BRISTOL MYERS SQUIBB,40.0,YR,M,Y,131.07,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93146761,9314676,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis necrotising,2013,Q2,1,I,20090325.0,20130514.0,20130529,20130529,EXP,US201002003426,BRISTOL MYERS SQUIBB,40.0,YR,M,Y,131.07,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Abdominal pain,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Lipase increased,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nephrolithiasis,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Polyuria,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Renal failure acute,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Renal failure chronic,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152351,9315235,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Abdominal pain,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Diarrhoea,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Lipase increased,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Nephrolithiasis,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Polyuria,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Renal failure acute,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Renal failure chronic,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152361,9315236,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2008.0,20130514.0,20130529,20130529,EXP,US200908006297,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,117.91,KG,20130529.0,,MD,US,US,2013,Q2,Elderly
93152391,9315239,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Anaemia,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200905002111,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,145.5,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152391,9315239,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200905002111,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,145.5,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152391,9315239,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Dehydration,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200905002111,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,145.5,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152391,9315239,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200905002111,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,145.5,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152391,9315239,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Renal failure,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200905002111,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,145.5,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152391,9315239,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Vomiting,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200905002111,BRISTOL MYERS SQUIBB,69.0,YR,F,Y,145.5,KG,20130529.0,,LW,US,US,2013,Q2,Elderly
93152421,9315242,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Off label use,2013,Q2,1,I,20081130.0,20130514.0,20130529,20130529,EXP,US201002003680,BRISTOL MYERS SQUIBB,43.0,YR,M,Y,106.12,KG,20130529.0,,LW,US,US,2013,Q2,Adult
93152421,9315242,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis,2013,Q2,1,I,20081130.0,20130514.0,20130529,20130529,EXP,US201002003680,BRISTOL MYERS SQUIBB,43.0,YR,M,Y,106.12,KG,20130529.0,,LW,US,US,2013,Q2,Adult
93152421,9315242,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis chronic,2013,Q2,1,I,20081130.0,20130514.0,20130529,20130529,EXP,US201002003680,BRISTOL MYERS SQUIBB,43.0,YR,M,Y,106.12,KG,20130529.0,,LW,US,US,2013,Q2,Adult
93152521,9315252,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Cholelithiasis,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis relapsing,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose decreased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Blood glucose increased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Cholelithiasis,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Pancreatitis relapsing,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93152521,9315252,5,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q2,Weight decreased,2013,Q2,1,I,2007.0,20130514.0,20130529,20130529,EXP,US200907000484,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,90.7,KG,20130529.0,,MD,US,US,2013,Q2,Adult
93157471,9315747,2,I,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Adrenocortical insufficiency acute,2013,Q2,1,I,,20130522.0,20130529,20130529,EXP,JP-PFIZER INC-2013157682,PFIZER,50.0,YR,F,Y,,,20130528.0,,MD,JP,JP,2013,Q2,Adult
93157471,9315747,2,I,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Blood pressure decreased,2013,Q2,1,I,,20130522.0,20130529,20130529,EXP,JP-PFIZER INC-2013157682,PFIZER,50.0,YR,F,Y,,,20130528.0,,MD,JP,JP,2013,Q2,Adult
93157471,9315747,2,I,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Decreased appetite,2013,Q2,1,I,,20130522.0,20130529,20130529,EXP,JP-PFIZER INC-2013157682,PFIZER,50.0,YR,F,Y,,,20130528.0,,MD,JP,JP,2013,Q2,Adult
93157471,9315747,2,I,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Drug interaction,2013,Q2,1,I,,20130522.0,20130529,20130529,EXP,JP-PFIZER INC-2013157682,PFIZER,50.0,YR,F,Y,,,20130528.0,,MD,JP,JP,2013,Q2,Adult
93157471,9315747,2,I,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q2,Malaise,2013,Q2,1,I,,20130522.0,20130529,20130529,EXP,JP-PFIZER INC-2013157682,PFIZER,50.0,YR,F,Y,,,20130528.0,,MD,JP,JP,2013,Q2,Adult
93228681,9322868,1,PS,EXENATIDE,1,,,,,,D,,,,5,MG,,BID,2013,Q2,Abortion induced,2013,Q2,1,I,,20130527.0,20130602,20130602,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-18964999,BRISTOL MYERS SQUIBB,32.0,YR,F,Y,96.8,KG,20130602.0,,CN,GB,GB,2013,Q2,Young Adult
93228681,9322868,1,PS,EXENATIDE,1,,,,,,D,,,,5,MG,,BID,2013,Q2,Pregnancy,2013,Q2,1,I,,20130527.0,20130602,20130602,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-18964999,BRISTOL MYERS SQUIBB,32.0,YR,F,Y,96.8,KG,20130602.0,,CN,GB,GB,2013,Q2,Young Adult
93283291,9328329,5,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,,,2013,Q2,Fungal infection,2013,Q2,1,I,2012.0,20120703.0,20130604,20130604,PER,US-SANOFI-AVENTIS-2012SA048297,AVENTIS,63.0,YR,F,Y,,,20130604.0,,CN,US,US,2013,Q2,Adult
93283291,9328329,5,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,,,2013,Q2,Hyperglycaemia,2013,Q2,1,I,2012.0,20120703.0,20130604,20130604,PER,US-SANOFI-AVENTIS-2012SA048297,AVENTIS,63.0,YR,F,Y,,,20130604.0,,CN,US,US,2013,Q2,Adult
93283291,9328329,5,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,,,2013,Q2,Sinusitis,2013,Q2,1,I,2012.0,20120703.0,20130604,20130604,PER,US-SANOFI-AVENTIS-2012SA048297,AVENTIS,63.0,YR,F,Y,,,20130604.0,,CN,US,US,2013,Q2,Adult
93326051,9332605,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Formication,2013,Q2,1,I,20130314.0,20130524.0,20130603,20130603,EXP,2013160573,PFIZER,57.0,YR,F,N,104.0,KG,20130529.0,,CN,GB,,2013,Q2,Adult
93326051,9332605,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Insomnia,2013,Q2,1,I,20130314.0,20130524.0,20130603,20130603,EXP,2013160573,PFIZER,57.0,YR,F,N,104.0,KG,20130529.0,,CN,GB,,2013,Q2,Adult
93326051,9332605,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Irritability,2013,Q2,1,I,20130314.0,20130524.0,20130603,20130603,EXP,2013160573,PFIZER,57.0,YR,F,N,104.0,KG,20130529.0,,CN,GB,,2013,Q2,Adult
93326051,9332605,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Pruritus generalised,2013,Q2,1,I,20130314.0,20130524.0,20130603,20130603,EXP,2013160573,PFIZER,57.0,YR,F,N,104.0,KG,20130529.0,,CN,GB,,2013,Q2,Adult
93326051,9332605,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Restlessness,2013,Q2,1,I,20130314.0,20130524.0,20130603,20130603,EXP,2013160573,PFIZER,57.0,YR,F,N,104.0,KG,20130529.0,,CN,GB,,2013,Q2,Adult
93326051,9332605,3,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q2,Tremor,2013,Q2,1,I,20130314.0,20130524.0,20130603,20130603,EXP,2013160573,PFIZER,57.0,YR,F,N,104.0,KG,20130529.0,,CN,GB,,2013,Q2,Adult
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Acidosis,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Anuria,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Azotaemia,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Blood creatinine abnormal,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Dehydration,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Diarrhoea,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Drug level above therapeutic,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Malaise,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Renal failure acute,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93701321,9370132,5,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q2,Vomiting,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,PHHY2013GB062225,SANDOZ,72.0,YR,M,Y,98.0,KG,20130626.0,,OT,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Acidosis,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Anuria,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Azotaemia,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Blood creatinine abnormal,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Dehydration,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Diarrhoea,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Drug level above therapeutic,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Malaise,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Renal failure acute,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93705811,9370581,5,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q2,Vomiting,2013,Q2,1,I,20130418.0,20130618.0,20130626,20130626,EXP,GB-TEVA-413767ISR,TEVA,72.0,YR,M,Y,98.0,KG,20130626.0,,MD,GB,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Acidosis,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Anuria,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Azotaemia,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Blood creatinine abnormal,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Dehydration,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Diarrhoea,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Drug level above therapeutic,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Malaise,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Renal failure acute,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93739371,9373937,7,C,EXENATIDE,1,,,,,,D,,,,10,UG,,,2013,Q2,Vomiting,2013,Q2,1,I,20130418.0,20130618.0,20130628,20130628,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19040708,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,98.0,KG,20130628.0,,CN,DE,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Acidosis,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Anuria,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Azotaemia,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Blood creatinine abnormal,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Dehydration,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Diarrhoea,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Drug level above therapeutic,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Malaise,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Renal failure acute,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
93754241,9375424,5,C,EXENATIDE,1,UNKNOWN,"10 MCG, UNK",,,,U, UNCONFIRMED,,,10,UG,,,2013,Q2,Vomiting,2013,Q2,1,I,20130420.0,20130618.0,20130628,20130628,EXP,GB-WATSON-2013-11541,WATSON,72.0,YR,M,Y,,,20130628.0,,OT,GB,GB,2013,Q2,Elderly
99047961,9904796,7,C,BYETTA (EXENATIDE) (SOLUTION),2,,,,,,,,,,,,,,2013,Q2,Eyelid oedema,2013,Q2,1,I,20120322.0,20120525.0,20130305,20130305,PER,163-21880-12033598,CELGENE,44.0,YR,F,N,,,20120525.0,N,MD,US,,2013,Q2,Adult
99047961,9904796,7,C,BYETTA (EXENATIDE) (SOLUTION),2,,,,,,,,,,,,,,2013,Q2,Fatigue,2013,Q2,1,I,20120322.0,20120525.0,20130305,20130305,PER,163-21880-12033598,CELGENE,44.0,YR,F,N,,,20120525.0,N,MD,US,,2013,Q2,Adult
99047961,9904796,7,C,BYETTA (EXENATIDE) (SOLUTION),2,,,,,,,,,,,,,,2013,Q2,Rash generalised,2013,Q2,1,I,20120322.0,20120525.0,20130305,20130305,PER,163-21880-12033598,CELGENE,44.0,YR,F,N,,,20120525.0,N,MD,US,,2013,Q2,Adult
99047961,9904796,7,C,BYETTA (EXENATIDE) (SOLUTION),2,,,,,,,,,,,,,,2013,Q2,Skin burning sensation,2013,Q2,1,I,20120322.0,20120525.0,20130305,20130305,PER,163-21880-12033598,CELGENE,44.0,YR,F,N,,,20120525.0,N,MD,US,,2013,Q2,Adult
99047961,9904796,7,C,BYETTA (EXENATIDE) (SOLUTION),2,,,,,,,,,,,,,,2013,Q2,Swelling face,2013,Q2,1,I,20120322.0,20120525.0,20130305,20130305,PER,163-21880-12033598,CELGENE,44.0,YR,F,N,,,20120525.0,N,MD,US,,2013,Q2,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal discomfort,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Arthritis,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Bile duct stone,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Off label use,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal injury,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
80326162,8032616,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Rotator cuff syndrome,2013,Q3,2,F,20080314.0,20130708.0,20110527,20130711,EXP,US200903003319,BRISTOL MYERS SQUIBB,53.0,YR,F,Y,81.63,KG,20130711.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Gait disturbance,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Gastritis,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nerve injury,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Off label use,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis acute,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis chronic,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal failure,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92421773,9242177,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,3,F,20080220.0,20130625.0,20130419,20130701,EXP,US200906005605,BRISTOL MYERS SQUIBB,57.0,YR,F,Y,95.24,KG,20130701.0,,CN,US,US,2013,Q3,Adult
92879752,9287975,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal hernia,2013,Q3,2,F,2006.0,20130731.0,20130514,20130807,EXP,US200910004070,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,83.9,KG,20130807.0,,CN,US,US,2013,Q3,Adult
92879752,9287975,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cholecystitis acute,2013,Q3,2,F,2006.0,20130731.0,20130514,20130807,EXP,US200910004070,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,83.9,KG,20130807.0,,CN,US,US,2013,Q3,Adult
92879752,9287975,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis,2013,Q3,2,F,2006.0,20130731.0,20130514,20130807,EXP,US200910004070,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,83.9,KG,20130807.0,,CN,US,US,2013,Q3,Adult
92879752,9287975,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal disorder,2013,Q3,2,F,2006.0,20130731.0,20130514,20130807,EXP,US200910004070,BRISTOL MYERS SQUIBB,61.0,YR,M,Y,83.9,KG,20130807.0,,CN,US,US,2013,Q3,Adult
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Arthralgia,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Asthenia,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood disorder,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dizziness,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Drug ineffective,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Energy increased,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Erythema,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hangnail,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hepatic steatosis,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hepatomegaly,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Inflammation,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site bruising,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site erythema,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site extravasation,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Product quality issue,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Skin wrinkling,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Sluggishness,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Thrombosis,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Underdose,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
92961964,9296196,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,4,F,2013.0,20130905.0,20130517,20130918,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18587949,BRISTOL MYERS SQUIBB,66.0,YR,F,Y,103.4,KG,20130918.0,,MD,US,US,2013,Q3,Elderly
93763601,9376360,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Drug ineffective,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dyspnoea,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Heart rate decreased,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Muscular weakness,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,2,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Drug ineffective,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dyspnoea,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Heart rate decreased,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Muscular weakness,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93763601,9376360,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,1,I,2007.0,20130621.0,20130701,20130701,EXP,US201001001907,BRISTOL MYERS SQUIBB,63.0,YR,M,Y,81.63,KG,20130701.0,,MD,US,US,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Abdominal distension,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Bronchopneumonia,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Cardiac disorder,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Cardiac failure congestive,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Cardiomegaly,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Cardiopulmonary failure,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Chronic obstructive pulmonary disease,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Cough,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Diabetes mellitus inadequate control,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Diabetic eye disease,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Diabetic microangiopathy,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Diabetic retinopathy,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Dilatation ventricular,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Dizziness,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Dyslipidaemia,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Dyspnoea,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Fluid overload,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Hypertension,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Hypoxia,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Left ventricular hypertrophy,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Liver function test abnormal,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Lower respiratory tract infection,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Macular oedema,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Malaise,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Microalbuminuria,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Micturition disorder,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Nausea,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Neovascularisation,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Nephrotic syndrome,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Obstructive airways disorder,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Oedema,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Oedema peripheral,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Penile swelling,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Pulmonary function test decreased,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Pulmonary oedema,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Renal failure,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Renal impairment,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Scrotal swelling,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Systolic dysfunction,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93780991,9378099,2,SS,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,UNKNOWN,,2013,Q3,Vomiting,2013,Q3,1,I,20070813.0,20130624.0,20130701,20130701,EXP,GB-GLAXOSMITHKLINE-B0799637A,GLAXOSMITHKLINE,54.0,YR,M,Y,95,KG,20130701.0,,MD,GB,GB,2013,Q3,Adult
93868931,9386893,6,C,EXENATIDE (EXENATIDE),1,,,,,,,,,,,,,,2013,Q3,Diarrhoea,2013,Q3,1,I,20130418.0,20130618.0,20130702,20130702,EXP,AUR-APL-2013-05229,AUROBINDO,72.0,YR,M,N,,,20130701.0,,,GB,,2013,Q3,Elderly
93868931,9386893,6,C,EXENATIDE (EXENATIDE),1,,,,,,,,,,,,,,2013,Q3,Renal failure acute,2013,Q3,1,I,20130418.0,20130618.0,20130702,20130702,EXP,AUR-APL-2013-05229,AUROBINDO,72.0,YR,M,N,,,20130701.0,,,GB,,2013,Q3,Elderly
93868931,9386893,6,C,EXENATIDE (EXENATIDE),1,,,,,,,,,,,,,,2013,Q3,Vomiting,2013,Q3,1,I,20130418.0,20130618.0,20130702,20130702,EXP,AUR-APL-2013-05229,AUROBINDO,72.0,YR,M,N,,,20130701.0,,,GB,,2013,Q3,Elderly
93888851,9388885,1,PS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q3,Erectile dysfunction,2013,Q3,1,I,20120612.0,20130701.0,20130708,20130708,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19062942,BRISTOL MYERS SQUIBB,39.0,YR,M,Y,174.0,KG,20130708.0,,CN,GB,GB,2013,Q3,Adult
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood creatinine increased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cardiac flutter,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dizziness,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Fatigue,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Influenza,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site haemorrhage,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Intentional drug misuse,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood creatinine increased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cardiac flutter,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dizziness,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Fatigue,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Influenza,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site haemorrhage,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Intentional drug misuse,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94080491,9408049,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,1,I,20120515.0,20130712.0,20130718,20130718,EXP,US201205009547,BRISTOL MYERS SQUIBB,71.0,YR,M,Y,81.63,KG,20130718.0,,CN,US,US,2013,Q3,Elderly
94089271,9408927,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,10,UG,,,2013,Q3,Bile duct cancer,2013,Q3,1,I,,20130717.0,20130719,20130719,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19117878,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,80.0,KG,20130719.0,,CN,GB,GB,2013,Q3,Adult
94089271,9408927,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,10,UG,,,2013,Q3,Pancreatic carcinoma,2013,Q3,1,I,,20130717.0,20130719,20130719,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19117878,BRISTOL MYERS SQUIBB,56.0,YR,F,Y,80.0,KG,20130719.0,,CN,GB,GB,2013,Q3,Adult
94095212,9409521,3,SS,EXENATIDE,1,SUBCUTANEOUS,,,,,D, UNKNOWN,,,5,UG,,,2013,Q3,Loss of consciousness,2013,Q3,2,F,,20130812.0,20130719,20130819,EXP,GB-SANOFI-AVENTIS-2013SA071421,AVENTIS,70.0,YR,F,Y,,,20130819.0,,OT,GB,GB,2013,Q3,Elderly
94095212,9409521,3,SS,EXENATIDE,1,SUBCUTANEOUS,,,,,D, UNKNOWN,,,5,UG,,,2013,Q3,Palpitations,2013,Q3,2,F,,20130812.0,20130719,20130819,EXP,GB-SANOFI-AVENTIS-2013SA071421,AVENTIS,70.0,YR,F,Y,,,20130819.0,,OT,GB,GB,2013,Q3,Elderly
94095212,9409521,3,SS,EXENATIDE,1,SUBCUTANEOUS,,,,,D, UNKNOWN,,,5,UG,,,2013,Q3,Seizure like phenomena,2013,Q3,2,F,,20130812.0,20130719,20130819,EXP,GB-SANOFI-AVENTIS-2013SA071421,AVENTIS,70.0,YR,F,Y,,,20130819.0,,OT,GB,GB,2013,Q3,Elderly
94114751,9411475,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diarrhoea,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Feeling jittery,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site haemorrhage,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Transitional cell carcinoma,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diarrhoea,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Feeling jittery,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site haemorrhage,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94114751,9411475,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Transitional cell carcinoma,2013,Q3,1,I,2008.0,20130709.0,20130722,20130722,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18055277,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,86.17,KG,20130722.0,,CN,US,US,2013,Q3,Elderly
94244891,9424489,1,PS,"BYETTA (EXENATIDE) PEN , DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D, UNKNOWN,20140423,,10,UG,,BID,2013,Q3,Gallbladder disorder,2013,Q3,1,I,20130512.0,,20130726,20130726,DIR,,,55.0,YR,F,N,86.8,KG,20130718.0,,PH,US,,2013,Q3,Adult
94244891,9424489,1,PS,"BYETTA (EXENATIDE) PEN , DISPOSABLE",1,SUBCUTANEOUS,,,,Y,D, UNKNOWN,20140423,,10,UG,,BID,2013,Q3,Pancreatitis acute,2013,Q3,1,I,20130512.0,,20130726,20130726,DIR,,,55.0,YR,F,N,86.8,KG,20130718.0,,PH,US,,2013,Q3,Adult
94655041,9465504,1,PS,EXENATIDE,1,SUBCUTANEOUS,5 MICROGRAMS FOR FOUR WEEKS THEN INCREASED TO 10 MICROGRAMS.,,,,D,,,,5,UG,,,2013,Q3,Cholecystitis acute,2013,Q3,1,I,20121019.0,20130808.0,20130820,20130820,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19179720,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,82.6,KG,20130820.0,,CN,GB,GB,2013,Q3,Adult
94655041,9465504,2,SS,EXENATIDE,1,SUBCUTANEOUS,5 MICROGRAMS FOR FOUR WEEKS THEN INCREASED TO 10 MICROGRAMS.?10AUG2012-ONG?SEP2012-19OCT2012.,,,,D,,,,10,UG,,,2013,Q3,Cholecystitis acute,2013,Q3,1,I,20121019.0,20130808.0,20130820,20130820,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19179720,BRISTOL MYERS SQUIBB,38.0,YR,F,Y,82.6,KG,20130820.0,,CN,GB,GB,2013,Q3,Adult
94742402,9474240,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,2,F,20121214.0,20130813.0,20130823,20130823,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18576561,BRISTOL MYERS SQUIBB,79.0,YR,F,Y,95.24,KG,20130823.0,,CN,US,US,2013,Q3,Elderly
94742402,9474240,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Carpal tunnel syndrome,2013,Q3,2,F,20121214.0,20130813.0,20130823,20130823,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18576561,BRISTOL MYERS SQUIBB,79.0,YR,F,Y,95.24,KG,20130823.0,,CN,US,US,2013,Q3,Elderly
94742402,9474240,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Drug dose omission,2013,Q3,2,F,20121214.0,20130813.0,20130823,20130823,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18576561,BRISTOL MYERS SQUIBB,79.0,YR,F,Y,95.24,KG,20130823.0,,CN,US,US,2013,Q3,Elderly
94742402,9474240,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Macular hole,2013,Q3,2,F,20121214.0,20130813.0,20130823,20130823,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18576561,BRISTOL MYERS SQUIBB,79.0,YR,F,Y,95.24,KG,20130823.0,,CN,US,US,2013,Q3,Elderly
94742402,9474240,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Tendon rupture,2013,Q3,2,F,20121214.0,20130813.0,20130823,20130823,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18576561,BRISTOL MYERS SQUIBB,79.0,YR,F,Y,95.24,KG,20130823.0,,CN,US,US,2013,Q3,Elderly
94742691,9474269,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,10,UG,,QD,2013,Q3,Pancreatic carcinoma,2013,Q3,1,I,20110709.0,20130809.0,20130823,20130823,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19182906,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,,,20130823.0,,CN,GB,GB,2013,Q3,Elderly
94742691,9474269,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,10,UG,,QD,2013,Q3,Pancreatitis,2013,Q3,1,I,20110709.0,20130809.0,20130823,20130823,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19182906,BRISTOL MYERS SQUIBB,78.0,YR,M,Y,,,20130823.0,,CN,GB,GB,2013,Q3,Elderly
94856511,9485651,1,PS,EXENATIDE,1,SUBCUTANEOUS,1DF:10 MCG/0.04ML SOLN FOR INJ 2.4ML PRE-FILLED,,,,D,,,,1,DF,,BID,2013,Q3,Pancreatic cyst,2013,Q3,1,I,,20130826.0,20130829,20130829,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19218403,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,,,20130829.0,,CN,GB,GB,2013,Q3,Adult
94904001,9490400,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,,,2013,Q3,Loss of consciousness,2013,Q3,1,I,,20130820.0,20130830,20130830,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19204387,BRISTOL MYERS SQUIBB,7.0,DEC,F,Y,,,20130830.0,,CN,GB,GB,2013,Q3,Child
94904001,9490400,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,,,2013,Q3,Palpitations,2013,Q3,1,I,,20130820.0,20130830,20130830,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19204387,BRISTOL MYERS SQUIBB,7.0,DEC,F,Y,,,20130830.0,,CN,GB,GB,2013,Q3,Child
94904001,9490400,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,,,2013,Q3,Seizure like phenomena,2013,Q3,1,I,,20130820.0,20130830,20130830,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19204387,BRISTOL MYERS SQUIBB,7.0,DEC,F,Y,,,20130830.0,,CN,GB,GB,2013,Q3,Child
95214241,9521424,5,SS,"BYETTA (EXENATIDE) PEN , DISPOSABLE",1,SUBCUTANEOUS,"2 DOSAGE FORMS (1 DOSAGE FORMS, 2 IN 1D) SUBCUTANEOUS",,,,,,,,2,DF,,,2013,Q3,Blood pressure increased,2013,Q3,1,I,,20130829.0,20130911,20130911,EXP,AUR-APL-2013-07436,AUROBINDO,60.0,YR,F,N,,,20130910.0,,CN,US,,2013,Q3,Adult
95214241,9521424,5,SS,"BYETTA (EXENATIDE) PEN , DISPOSABLE",1,SUBCUTANEOUS,"2 DOSAGE FORMS (1 DOSAGE FORMS, 2 IN 1D) SUBCUTANEOUS",,,,,,,,2,DF,,,2013,Q3,Hernia,2013,Q3,1,I,,20130829.0,20130911,20130911,EXP,AUR-APL-2013-07436,AUROBINDO,60.0,YR,F,N,,,20130910.0,,CN,US,,2013,Q3,Adult
95214241,9521424,5,SS,"BYETTA (EXENATIDE) PEN , DISPOSABLE",1,SUBCUTANEOUS,"2 DOSAGE FORMS (1 DOSAGE FORMS, 2 IN 1D) SUBCUTANEOUS",,,,,,,,2,DF,,,2013,Q3,Mycosis fungoides,2013,Q3,1,I,,20130829.0,20130911,20130911,EXP,AUR-APL-2013-07436,AUROBINDO,60.0,YR,F,N,,,20130910.0,,CN,US,,2013,Q3,Adult
95379181,9537918,18,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q3,Erythema,2013,Q3,1,I,20121029.0,20130913.0,20130919,20130919,EXP,PHHY2013GB101546,SANDOZ,67.0,YR,F,Y,,,20130919.0,,OT,GB,GB,2013,Q3,Elderly
95379181,9537918,18,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q3,Local swelling,2013,Q3,1,I,20121029.0,20130913.0,20130919,20130919,EXP,PHHY2013GB101546,SANDOZ,67.0,YR,F,Y,,,20130919.0,,OT,GB,GB,2013,Q3,Elderly
95379181,9537918,18,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q3,Malaise,2013,Q3,1,I,20121029.0,20130913.0,20130919,20130919,EXP,PHHY2013GB101546,SANDOZ,67.0,YR,F,Y,,,20130919.0,,OT,GB,GB,2013,Q3,Elderly
95379181,9537918,18,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q3,Pyrexia,2013,Q3,1,I,20121029.0,20130913.0,20130919,20130919,EXP,PHHY2013GB101546,SANDOZ,67.0,YR,F,Y,,,20130919.0,,OT,GB,GB,2013,Q3,Elderly
95379181,9537918,18,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q3,Tenderness,2013,Q3,1,I,20121029.0,20130913.0,20130919,20130919,EXP,PHHY2013GB101546,SANDOZ,67.0,YR,F,Y,,,20130919.0,,OT,GB,GB,2013,Q3,Elderly
95379181,9537918,18,C,EXENATIDE,1,,"10 UG, BID",,,,U,,,,10,UG,,BID,2013,Q3,Treatment failure,2013,Q3,1,I,20121029.0,20130913.0,20130919,20130919,EXP,PHHY2013GB101546,SANDOZ,67.0,YR,F,Y,,,20130919.0,,OT,GB,GB,2013,Q3,Elderly
95539611,9553961,18,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q3,Erythema,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GB-TEVA-433188ISR,TEVA,67.0,YR,F,Y,,,20130925.0,,PH,GB,GB,2013,Q3,Elderly
95539611,9553961,18,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q3,Local swelling,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GB-TEVA-433188ISR,TEVA,67.0,YR,F,Y,,,20130925.0,,PH,GB,GB,2013,Q3,Elderly
95539611,9553961,18,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q3,Malaise,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GB-TEVA-433188ISR,TEVA,67.0,YR,F,Y,,,20130925.0,,PH,GB,GB,2013,Q3,Elderly
95539611,9553961,18,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q3,Pyrexia,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GB-TEVA-433188ISR,TEVA,67.0,YR,F,Y,,,20130925.0,,PH,GB,GB,2013,Q3,Elderly
95539611,9553961,18,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q3,Tenderness,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GB-TEVA-433188ISR,TEVA,67.0,YR,F,Y,,,20130925.0,,PH,GB,GB,2013,Q3,Elderly
95539611,9553961,18,C,EXENATIDE,1,,20 MICROGRAM DAILY;,,,,D,,,,10,UG,,BID,2013,Q3,Treatment failure,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GB-TEVA-433188ISR,TEVA,67.0,YR,F,Y,,,20130925.0,,PH,GB,GB,2013,Q3,Elderly
95584071,9558407,18,C,EXENATIDE,1,UNKNOWN,"10 G, BID",,,,U,,,,10,UG,,,2013,Q3,Erythema,2013,Q3,1,I,20121029.0,20130913.0,20130926,20130926,EXP,GB-WATSON-2013-17008,WATSON,67.0,YR,F,Y,,,20130926.0,,CN,GB,GB,2013,Q3,Elderly
95584071,9558407,18,C,EXENATIDE,1,UNKNOWN,"10 G, BID",,,,U,,,,10,UG,,,2013,Q3,Local swelling,2013,Q3,1,I,20121029.0,20130913.0,20130926,20130926,EXP,GB-WATSON-2013-17008,WATSON,67.0,YR,F,Y,,,20130926.0,,CN,GB,GB,2013,Q3,Elderly
95584071,9558407,18,C,EXENATIDE,1,UNKNOWN,"10 G, BID",,,,U,,,,10,UG,,,2013,Q3,Malaise,2013,Q3,1,I,20121029.0,20130913.0,20130926,20130926,EXP,GB-WATSON-2013-17008,WATSON,67.0,YR,F,Y,,,20130926.0,,CN,GB,GB,2013,Q3,Elderly
95584071,9558407,18,C,EXENATIDE,1,UNKNOWN,"10 G, BID",,,,U,,,,10,UG,,,2013,Q3,Pyrexia,2013,Q3,1,I,20121029.0,20130913.0,20130926,20130926,EXP,GB-WATSON-2013-17008,WATSON,67.0,YR,F,Y,,,20130926.0,,CN,GB,GB,2013,Q3,Elderly
95584071,9558407,18,C,EXENATIDE,1,UNKNOWN,"10 G, BID",,,,U,,,,10,UG,,,2013,Q3,Tenderness,2013,Q3,1,I,20121029.0,20130913.0,20130926,20130926,EXP,GB-WATSON-2013-17008,WATSON,67.0,YR,F,Y,,,20130926.0,,CN,GB,GB,2013,Q3,Elderly
95584071,9558407,18,C,EXENATIDE,1,UNKNOWN,"10 G, BID",,,,U,,,,10,UG,,,2013,Q3,Treatment failure,2013,Q3,1,I,20121029.0,20130913.0,20130926,20130926,EXP,GB-WATSON-2013-17008,WATSON,67.0,YR,F,Y,,,20130926.0,,CN,GB,GB,2013,Q3,Elderly
95591591,9559159,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q3,Dysplasia,2013,Q3,1,I,20130731.0,20130913.0,20130927,20130927,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19394923,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,71,KG,20130927.0,,CN,GB,GB,2013,Q3,Adult
95591591,9559159,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,,,,,2013,Q3,Mucinous cystadenocarcinoma of pancreas,2013,Q3,1,I,20130731.0,20130913.0,20130927,20130927,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19394923,BRISTOL MYERS SQUIBB,48.0,YR,F,Y,71,KG,20130927.0,,CN,GB,GB,2013,Q3,Adult
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Erythema,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Inflammation,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Local swelling,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Malaise,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Pyrexia,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Tenderness,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620681,9562068,14,C,EXENATIDE 9EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Treatment failure,2013,Q3,1,I,20121029.0,20130913.0,20130925,20130925,EXP,GER/UKI/13/0034599,DR REDDYS,67.0,YR,F,N,,,20130917.0,,PH,GB,,2013,Q3,Elderly
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal pain upper,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Coma,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diabetic ketoacidosis,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Loss of consciousness,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Mental status changes,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Off label use,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis necrotising,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal injury,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Sepsis,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal pain upper,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Coma,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diabetic ketoacidosis,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Loss of consciousness,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Mental status changes,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Off label use,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis necrotising,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal injury,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
95620802,9562080,4,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Sepsis,2013,Q3,2,F,200711.0,20130911.0,20130927,20130927,EXP,US200905006069,BRISTOL MYERS SQUIBB,54.0,YR,M,Y,90.7,KG,20130927.0,,CN,US,US,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Abdominal distension,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Bronchopneumonia,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiac disorder,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiac failure congestive,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiomegaly,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiopulmonary failure,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Chronic obstructive pulmonary disease,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cough,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetes mellitus inadequate control,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetic eye disease,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetic microangiopathy,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetic retinopathy,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dilatation ventricular,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dizziness,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dyslipidaemia,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dyspnoea,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Fluid overload,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Hypertension,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Hypoxia,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Left ventricular hypertrophy,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Liver function test abnormal,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Lower respiratory tract infection,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Macular oedema,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Malaise,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Microalbuminuria,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Micturition disorder,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Neovascularisation,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Nephrotic syndrome,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Obstructive airways disorder,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Oedema,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Oedema peripheral,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Penile swelling,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Pulmonary function test decreased,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Pulmonary oedema,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Renal failure,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Renal impairment,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Scrotal swelling,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Systolic dysfunction,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
85496456,8549645,3,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Vomiting,2013,Q3,6,F,20070813.0,20131121.0,20120507,20131205,EXP,GB-WATSON-2012-11748,WATSON,59.0,YR,M,Y,95,KG,20131205.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Abdominal distension,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Blood glucose fluctuation,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Bronchopneumonia,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiac disorder,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiac failure congestive,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiomegaly,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cardiopulmonary failure,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Chronic obstructive pulmonary disease,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Cough,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetic eye disease,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetic microangiopathy,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Diabetic retinopathy,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dilatation ventricular,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dizziness,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dyslipidaemia,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Dyspnoea,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Fluid overload,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Hypertension,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Hypoxia,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Left ventricular hypertrophy,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Liver function test abnormal,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Lower respiratory tract infection,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Macular oedema,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Malaise,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Microalbuminuria,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Micturition disorder,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Neovascularisation,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Nephrotic syndrome,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Obstructive airways disorder,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Oedema,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Oedema peripheral,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Penile swelling,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Pulmonary function test decreased,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Pulmonary oedema,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Renal failure,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Renal impairment,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Scrotal swelling,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Systolic dysfunction,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
86511782,8651178,4,SS,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Vomiting,2013,Q3,2,F,20070813.0,20131121.0,20120705,20131127,EXP,GB-PFIZER INC-2012157807,PFIZER,59.0,YR,M,Y,95,KG,20131127.0,,CN,GB,GB,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal pain,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cataract,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cholecystitis chronic,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cholelithiasis,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Constipation,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hypersensitivity,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nephrolithiasis,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
92452254,9245225,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal injury,2013,Q3,4,F,200712.0,20130926.0,20130422,20131007,EXP,US200911007305,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,117.01,KG,20131007.0,,CN,AU,US,2013,Q3,Adult
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal distension,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal pain,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Constipation,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Impaired gastric emptying,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site pain,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Overdose,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pruritus,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93091002,9309100,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Urticaria,2013,Q3,2,F,20130310.0,20130624.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18696427,BRISTOL MYERS SQUIBB,70.0,YR,F,Y,68.03,KG,20131126.0,,MD,US,US,2013,Q3,Elderly
93093582,9309358,6,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,6,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose fluctuation,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,6,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Decreased appetite,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,6,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,6,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,6,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,7,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,7,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose fluctuation,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,7,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Decreased appetite,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,7,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,7,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
93093582,9309358,7,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,2,F,201301.0,20130710.0,20130525,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18728246,BRISTOL MYERS SQUIBB,72.0,YR,F,Y,79.37,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
95953591,9595359,3,SS,EXENATIDE,1,UNKNOWN,BEFORE A MEAL,,,,D,,,,10,UG,,Q12H,2013,Q3,Dyspnoea,2013,Q3,1,I,20090629.0,20131001.0,20131004,20131004,EXP,US-ROCHE-1284387,ROCHE,48.0,YR,M,Y,,,20131004.0,,MD,US,US,2013,Q3,Adult
95953591,9595359,3,SS,EXENATIDE,1,UNKNOWN,BEFORE A MEAL,,,,D,,,,10,UG,,Q12H,2013,Q3,Laboratory test abnormal,2013,Q3,1,I,20090629.0,20131001.0,20131004,20131004,EXP,US-ROCHE-1284387,ROCHE,48.0,YR,M,Y,,,20131004.0,,MD,US,US,2013,Q3,Adult
95953591,9595359,3,SS,EXENATIDE,1,UNKNOWN,BEFORE A MEAL,,,,D,,,,10,UG,,Q12H,2013,Q3,Oesophageal food impaction,2013,Q3,1,I,20090629.0,20131001.0,20131004,20131004,EXP,US-ROCHE-1284387,ROCHE,48.0,YR,M,Y,,,20131004.0,,MD,US,US,2013,Q3,Adult
96016272,9601627,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Osteoporosis,2013,Q3,2,F,,20130924.0,20131007,20131007,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18031336,BRISTOL MYERS SQUIBB,75.0,YR,F,Y,104.31,KG,20131007.0,,CN,US,US,2013,Q3,Elderly
96016272,9601627,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Platelet count decreased,2013,Q3,2,F,,20130924.0,20131007,20131007,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18031336,BRISTOL MYERS SQUIBB,75.0,YR,F,Y,104.31,KG,20131007.0,,CN,US,US,2013,Q3,Elderly
96016272,9601627,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Spinal disorder,2013,Q3,2,F,,20130924.0,20131007,20131007,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18031336,BRISTOL MYERS SQUIBB,75.0,YR,F,Y,104.31,KG,20131007.0,,CN,US,US,2013,Q3,Elderly
96016272,9601627,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,2,F,,20130924.0,20131007,20131007,EXP,US-BRISTOL-MYERS SQUIBB COMPANY-18031336,BRISTOL MYERS SQUIBB,75.0,YR,F,Y,104.31,KG,20131007.0,,CN,US,US,2013,Q3,Elderly
96017341,9601734,14,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q3,Cellulitis,2013,Q3,1,I,20121029.0,20130917.0,20131002,20131002,EXP,ABR_01133_2013,ARBOR,67.0,YR,F,N,,,20130927.0,,,GB,,2013,Q3,Elderly
96017341,9601734,14,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q3,Disease progression,2013,Q3,1,I,20121029.0,20130917.0,20131002,20131002,EXP,ABR_01133_2013,ARBOR,67.0,YR,F,N,,,20130927.0,,,GB,,2013,Q3,Elderly
96017341,9601734,14,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q3,Rash,2013,Q3,1,I,20121029.0,20130917.0,20131002,20131002,EXP,ABR_01133_2013,ARBOR,67.0,YR,F,N,,,20130927.0,,,GB,,2013,Q3,Elderly
96017341,9601734,14,C,EXENATIDE,1,,,,,,,,,,,,,,2013,Q3,Treatment failure,2013,Q3,1,I,20121029.0,20130917.0,20131002,20131002,EXP,ABR_01133_2013,ARBOR,67.0,YR,F,N,,,20130927.0,,,GB,,2013,Q3,Elderly
96078241,9607824,1,PS,EXENATIDE,1,,"10MCG, BID, SQ",,,Y,D, C134242A,20150401,,10,UG,,BID,2013,Q3,Pancreatitis,2013,Q3,1,I,20130910.0,,20131007,20131007,DIR,,,62.0,YR,M,N,181.4,KG,20131004.0,,PH,US,,2013,Q3,Adult
96174381,9617438,15,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Fracture displacement,2013,Q3,1,I,201206.0,20130925.0,20131009,20131009,EXP,2012-003977,WARNER CHILCOTT,69.0,YR,F,N,90.9,KG,20131007.0,,,US,,2013,Q3,Elderly
96174381,9617438,15,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Fracture nonunion,2013,Q3,1,I,201206.0,20130925.0,20131009,20131009,EXP,2012-003977,WARNER CHILCOTT,69.0,YR,F,N,90.9,KG,20131007.0,,,US,,2013,Q3,Elderly
96174381,9617438,15,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Pathological fracture,2013,Q3,1,I,201206.0,20130925.0,20131009,20131009,EXP,2012-003977,WARNER CHILCOTT,69.0,YR,F,N,90.9,KG,20131007.0,,,US,,2013,Q3,Elderly
96174381,9617438,15,C,BYETTA (EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Periprosthetic fracture,2013,Q3,1,I,201206.0,20130925.0,20131009,20131009,EXP,2012-003977,WARNER CHILCOTT,69.0,YR,F,N,90.9,KG,20131007.0,,,US,,2013,Q3,Elderly
96295361,9629536,2,SS,EXENATIDE,1,SUBCUTANEOUS,10 MICROGRAM DAILY,,,,D,,,,,,,,2013,Q3,Hypoglycaemia,2013,Q3,1,I,,20131009.0,20131017,20131017,EXP,JP-009507513-1310JPN006250,MERCK,64.0,YR,F,Y,,,20131017.0,,CN,JP,JP,2013,Q3,Adult
96398631,9639863,5,C,Exenatide,1,UNKNOWN,UNK,,,,D, UNKNOWN,,,,,,,2013,Q3,Gastrointestinal haemorrhage,2013,Q3,1,I,20131008.0,20131017.0,20131023,20131023,EXP,GB-PERRIGO-13GB010644,PERRIGO,52.0,YR,F,Y,,,20131023.0,,PH,GB,GB,2013,Q3,Adult
96398631,9639863,5,C,Exenatide,1,UNKNOWN,UNK,,,,D, UNKNOWN,,,,,,,2013,Q3,Haematemesis,2013,Q3,1,I,20131008.0,20131017.0,20131023,20131023,EXP,GB-PERRIGO-13GB010644,PERRIGO,52.0,YR,F,Y,,,20131023.0,,PH,GB,GB,2013,Q3,Adult
96398631,9639863,5,C,Exenatide,1,UNKNOWN,UNK,,,,D, UNKNOWN,,,,,,,2013,Q3,Melaena,2013,Q3,1,I,20131008.0,20131017.0,20131023,20131023,EXP,GB-PERRIGO-13GB010644,PERRIGO,52.0,YR,F,Y,,,20131023.0,,PH,GB,GB,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal distension,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Abdominal pain upper,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Asthenia,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Chest pain,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diarrhoea,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dry skin,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dyspnoea,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Feeling jittery,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Flatulence,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Gastrointestinal hypomotility,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Glycosylated haemoglobin increased,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Headache,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hyperhidrosis,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Infection,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Musculoskeletal stiffness,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Swelling face,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96514762,9651476,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight increased,2013,Q3,2,F,20120326.0,20131008.0,20131029,20131029,PER,US201203008324,BRISTOL MYERS SQUIBB,45.0,YR,M,Y,135.15,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96651251,9665125,1,PS,EXENATIDE,1,SUBCUTANEOUS,OCT10-JAN11 5MCG?JAN11-4SEP13 10MCG,,,,D,,,,5,UG,,BID,2013,Q3,Renal impairment,2013,Q3,1,I,201111.0,20131022.0,20131101,20131101,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19644731,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,120.2,KG,20131101.0,,CN,GB,GB,2013,Q3,Adult
96651251,9665125,1,PS,EXENATIDE,1,SUBCUTANEOUS,OCT10-JAN11 5MCG?JAN11-4SEP13 10MCG,,,,D,,,,5,UG,,BID,2013,Q3,Renal ischaemia,2013,Q3,1,I,201111.0,20131022.0,20131101,20131101,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19644731,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,120.2,KG,20131101.0,,CN,GB,GB,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Constipation,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diarrhoea,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Dysphonia,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Fungal infection,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Gastrooesophageal reflux disease,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Headache,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Off label use,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Sinusitis,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Thyroid function test abnormal,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Tooth extraction,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96663282,9666328,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Vomiting,2013,Q3,2,F,201202.0,20131021.0,20131104,20131104,PER,US201207005649,BRISTOL MYERS SQUIBB,63.0,YR,F,Y,113.83,KG,20140510.0,N,CN,US,US,2013,Q3,Adult
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Arterial disorder,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Arterial occlusive disease,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cardiac disorder,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Coronary artery restenosis,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Drug ineffective,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Feeling abnormal,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Myocardial infarction,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Arterial disorder,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Arterial occlusive disease,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cardiac disorder,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Coronary artery restenosis,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Drug ineffective,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Feeling abnormal,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Myocardial infarction,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96802733,9680273,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Weight decreased,2013,Q3,3,F,200807.0,20131103.0,20131111,20131112,EXP,US201107002762,BRISTOL MYERS SQUIBB,69.0,YR,M,Y,90.7,KG,20131112.0,,CN,US,US,2013,Q3,Elderly
96814601,9681460,1,PS,EXENATIDE PEN DISPOSABLE,1,SUBCUTANEOUS,,,,,D,,,,600,UG,INJECTION,,2013,Q3,Coma,2013,Q3,1,I,,20131031.0,20131111,20131111,EXP,FR-BRISTOL-MYERS SQUIBB COMPANY-19788926,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20131111.0,,OT,FR,FR,2013,Q3,Adult
96814601,9681460,1,PS,EXENATIDE PEN DISPOSABLE,1,SUBCUTANEOUS,,,,,D,,,,600,UG,INJECTION,,2013,Q3,Hypoglycaemia,2013,Q3,1,I,,20131031.0,20131111,20131111,EXP,FR-BRISTOL-MYERS SQUIBB COMPANY-19788926,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20131111.0,,OT,FR,FR,2013,Q3,Adult
96814601,9681460,1,PS,EXENATIDE PEN DISPOSABLE,1,SUBCUTANEOUS,,,,,D,,,,600,UG,INJECTION,,2013,Q3,Overdose,2013,Q3,1,I,,20131031.0,20131111,20131111,EXP,FR-BRISTOL-MYERS SQUIBB COMPANY-19788926,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,,,20131111.0,,OT,FR,FR,2013,Q3,Adult
97068382,9706838,2,C,EXENATIDE,1,SUBCUTANEOUS,"2 MG, WEEKLY (1/W)",,,,D,,,,2,MG,INJECTION,/wk,2013,Q3,Hepatic function abnormal,2013,Q3,2,F,20131031.0,20131129.0,20131125,20131211,EXP,JP-ELI_LILLY_AND_COMPANY-JP201311005684,ELI LILLY AND CO,45.0,YR,F,Y,,,20131210.0,,CN,JP,JP,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Abdominal pain,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Dehydration,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Hypotonia,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Lethargy,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Nausea,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Renal failure acute,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Skin turgor decreased,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Tongue dry,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Vomiting,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Weight decreased,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97087752,9708775,2,SS,EXENATIDE,1,SUBCUTANEOUS,"20 MCG (10 MCG,2 IN 1 D)",,,,D,,,,5,UG,,BID,2013,Q3,Weight increased,2013,Q3,2,F,,20131126.0,20131125,20131209,EXP,TR-BRISTOL-MYERS SQUIBB COMPANY-19829878,BRISTOL MYERS SQUIBB,59.0,YR,F,Y,86.0,KG,20131209.0,,CN,DE,TR,2013,Q3,Adult
97102612,9710261,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Incorrect dose administered,2013,Q3,2,F,,20130403.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18737668,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,,,20131126.0,,CN,US,US,2013,Q3,Elderly
97102612,9710261,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,,20130403.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18737668,BRISTOL MYERS SQUIBB,71.0,YR,F,Y,,,20131126.0,,CN,US,US,2013,Q3,Elderly
97104342,9710434,2,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site haemorrhage,2013,Q3,2,F,20130526.0,20130602.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18987123,BRISTOL MYERS SQUIBB,57.0,YR,M,Y,113.38,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108732,9710873,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hyperhidrosis,2013,Q3,2,F,2005.0,20130907.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18065714,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,92.06,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108732,9710873,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,2005.0,20130907.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18065714,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,92.06,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108732,9710873,3,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,2005.0,20130907.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18065714,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,92.06,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108732,9710873,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hyperhidrosis,2013,Q3,2,F,2005.0,20130907.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18065714,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,92.06,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108732,9710873,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,2005.0,20130907.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18065714,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,92.06,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108732,9710873,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Nausea,2013,Q3,2,F,2005.0,20130907.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18065714,BRISTOL MYERS SQUIBB,64.0,YR,M,Y,92.06,KG,20131126.0,,CN,US,US,2013,Q3,Adult
97108782,9710878,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site extravasation,2013,Q3,2,F,,20130620.0,20131126,20131126,PER,US201205001752,BRISTOL MYERS SQUIBB,62.0,YR,M,Y,,,20131126.0,,CN,US,US,2013,Q3,Adult
97108782,9710878,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site haemorrhage,2013,Q3,2,F,,20130620.0,20131126,20131126,PER,US201205001752,BRISTOL MYERS SQUIBB,62.0,YR,M,Y,,,20131126.0,,CN,US,US,2013,Q3,Adult
97108782,9710878,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site nodule,2013,Q3,2,F,,20130620.0,20131126,20131126,PER,US201205001752,BRISTOL MYERS SQUIBB,62.0,YR,M,Y,,,20131126.0,,CN,US,US,2013,Q3,Adult
97108782,9710878,3,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site pain,2013,Q3,2,F,,20130620.0,20131126,20131126,PER,US201205001752,BRISTOL MYERS SQUIBB,62.0,YR,M,Y,,,20131126.0,,CN,US,US,2013,Q3,Adult
97110122,9711012,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,2,F,2008.0,20130422.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18589630,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,77.1,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97110122,9711012,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,2,F,2008.0,20130422.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18589630,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,77.1,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97110122,9711012,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Glycosylated haemoglobin increased,2013,Q3,2,F,2008.0,20130422.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18589630,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,77.1,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97110122,9711012,3,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site mass,2013,Q3,2,F,2008.0,20130422.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18589630,BRISTOL MYERS SQUIBB,72.0,YR,M,Y,77.1,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97113871,9711387,1,PS,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q3,Abdominal pain upper,2013,Q3,1,I,,20130828.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-19229053,BRISTOL MYERS SQUIBB,5.0,DEC,F,Y,,,20131126.0,,MD,US,US,2013,Q3,Child
97114731,9711473,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose abnormal,2013,Q3,1,I,2010.0,20130401.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18758292,BRISTOL MYERS SQUIBB,81.0,YR,F,Y,67.12,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97114731,9711473,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose decreased,2013,Q3,1,I,2010.0,20130401.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18758292,BRISTOL MYERS SQUIBB,81.0,YR,F,Y,67.12,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97114731,9711473,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Blood glucose increased,2013,Q3,1,I,2010.0,20130401.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18758292,BRISTOL MYERS SQUIBB,81.0,YR,F,Y,67.12,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97114731,9711473,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Injection site mass,2013,Q3,1,I,2010.0,20130401.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18758292,BRISTOL MYERS SQUIBB,81.0,YR,F,Y,67.12,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97114731,9711473,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Lymphoma,2013,Q3,1,I,2010.0,20130401.0,20131126,20131126,PER,US-BRISTOL-MYERS SQUIBB COMPANY-18758292,BRISTOL MYERS SQUIBB,81.0,YR,F,Y,67.12,KG,20131126.0,,CN,US,US,2013,Q3,Elderly
97159551,9715955,2,C,Exenatide,1,,,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131127,20131127,EXP,GB-DRREDDYS-GER/UKI/13/0035835,DR REDDYS,54.0,YR,M,Y,111.0,KG,20131127.0,,MD,GB,GB,2013,Q3,Adult
97159551,9715955,3,C,Exenatide,1,,,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131127,20131127,EXP,GB-DRREDDYS-GER/UKI/13/0035835,DR REDDYS,54.0,YR,M,Y,111.0,KG,20131127.0,,MD,GB,GB,2013,Q3,Adult
97324961,9732496,9,C,EXENATIDE,1,,UNK,,,,U,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131204,20131204,EXP,PHHY2013GB137345,SANDOZ,54.0,YR,M,Y,111,KG,20131129.0,,MD,GB,GB,2013,Q3,Adult
97324961,9732496,10,C,EXENATIDE,1,,UNK,,,,U,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131204,20131204,EXP,PHHY2013GB137345,SANDOZ,54.0,YR,M,Y,111,KG,20131129.0,,MD,GB,GB,2013,Q3,Adult
97326891,9732689,2,C,EXENATIDE,1,,UNK,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131204,20131204,EXP,GB-BAYER-2013-145018,BAYER,54.0,YR,M,Y,111,KG,20131204.0,,MD,GB,GB,2013,Q3,Adult
97326891,9732689,3,C,EXENATIDE,1,,UNK,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131204,20131204,EXP,GB-BAYER-2013-145018,BAYER,54.0,YR,M,Y,111,KG,20131204.0,,MD,GB,GB,2013,Q3,Adult
97336572,9733657,6,C,EXENATIDE (bydureon),2,SUBCUTANEOUS,"2 MG, 1/WEEK",,,,U,,,,2,MG,,/wk,2013,Q3,Obesity,2013,Q3,2,F,20130823.0,20131203.0,20131205,20131205,EXP,US-TAKEDA-2013TUS002221,TAKEDA,65.0,YR,M,Y,152,KG,20131205.0,,MD,US,US,2013,Q3,Elderly
97346491,9734649,9,C,Exenatide,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131206,20131206,EXP,GB-RANBAXY-2013R1-75818,RANBAXY,54.0,YR,M,Y,111,KG,20131206.0,,OT,GB,GB,2013,Q3,Adult
97346491,9734649,10,C,Exenatide,1,UNKNOWN,UNK,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131206,20131206,EXP,GB-RANBAXY-2013R1-75818,RANBAXY,54.0,YR,M,Y,111,KG,20131206.0,,OT,GB,GB,2013,Q3,Adult
97352871,9735287,3,C,EXENATIDE ( EXENATIDE),2,,,,,,,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131204,20131204,EXP,AUR-APL-2013-09975,AUROBINDO,54.0,YR,M,N,111,KG,20131203.0,,MD,GB,,2013,Q3,Adult
97414841,9741484,2,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131209,20131209,EXP,GB-MYLANLABS-2013S1026730,MYLAN,54.0,YR,M,Y,111,KG,20131209.0,,MD,GB,GB,2013,Q3,Adult
97414841,9741484,3,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131209,20131209,EXP,GB-MYLANLABS-2013S1026730,MYLAN,54.0,YR,M,Y,111,KG,20131209.0,,MD,GB,GB,2013,Q3,Adult
97441271,9744127,9,C,EXENATIDE,1,UNKNOWN,UNK,,,,U,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131210,20131210,EXP,GB-WATSON-2013-22600,WATSON,54.0,YR,M,Y,111,KG,20131210.0,,CN,GB,GB,2013,Q3,Adult
97441271,9744127,10,C,EXENATIDE,1,UNKNOWN,UNK,,,,U,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131210,20131210,EXP,GB-WATSON-2013-22600,WATSON,54.0,YR,M,Y,111,KG,20131210.0,,CN,GB,GB,2013,Q3,Adult
97444781,9744478,9,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131210,20131210,EXP,GB-TEVA-449112ISR,TEVA,54.0,YR,M,Y,111,KG,20131210.0,,MD,GB,GB,2013,Q3,Adult
97444781,9744478,10,C,EXENATIDE,1,,,,,,D,,,,,,,,2013,Q3,Pericarditis,2013,Q3,1,I,20131112.0,20131126.0,20131210,20131210,EXP,GB-TEVA-449112ISR,TEVA,54.0,YR,M,Y,111,KG,20131210.0,,MD,GB,GB,2013,Q3,Adult
97610041,9761004,2,I,EXENATIDE,1,UNKNOWN,"10 G,BID",,,,D,,,,,,,,2013,Q3,Adrenal insufficiency,2013,Q3,1,I,,20131202.0,20131216,20131216,EXP,JP-ACTAVIS-2013-22450,ACTAVIS,50.0,YR,F,Y,,,20131216.0,,MD,JP,JP,2013,Q3,Adult
97610041,9761004,2,I,EXENATIDE,1,UNKNOWN,"10 G,BID",,,,D,,,,,,,,2013,Q3,Drug interaction,2013,Q3,1,I,,20131202.0,20131216,20131216,EXP,JP-ACTAVIS-2013-22450,ACTAVIS,50.0,YR,F,Y,,,20131216.0,,MD,JP,JP,2013,Q3,Adult
97610041,9761004,2,I,EXENATIDE,1,UNKNOWN,"10 G,BID",,,,D,,,,,,,,2013,Q3,Drug level decreased,2013,Q3,1,I,,20131202.0,20131216,20131216,EXP,JP-ACTAVIS-2013-22450,ACTAVIS,50.0,YR,F,Y,,,20131216.0,,MD,JP,JP,2013,Q3,Adult
97610041,9761004,3,I,EXENATIDE,1,UNKNOWN,"5 G,BID",,,,D,,,,,,,,2013,Q3,Adrenal insufficiency,2013,Q3,1,I,,20131202.0,20131216,20131216,EXP,JP-ACTAVIS-2013-22450,ACTAVIS,50.0,YR,F,Y,,,20131216.0,,MD,JP,JP,2013,Q3,Adult
97610041,9761004,3,I,EXENATIDE,1,UNKNOWN,"5 G,BID",,,,D,,,,,,,,2013,Q3,Drug interaction,2013,Q3,1,I,,20131202.0,20131216,20131216,EXP,JP-ACTAVIS-2013-22450,ACTAVIS,50.0,YR,F,Y,,,20131216.0,,MD,JP,JP,2013,Q3,Adult
97610041,9761004,3,I,EXENATIDE,1,UNKNOWN,"5 G,BID",,,,D,,,,,,,,2013,Q3,Drug level decreased,2013,Q3,1,I,,20131202.0,20131216,20131216,EXP,JP-ACTAVIS-2013-22450,ACTAVIS,50.0,YR,F,Y,,,20131216.0,,MD,JP,JP,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Acute respiratory failure,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Anaemia,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Bacterial disease carrier,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Cholelithiasis,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Diarrhoea,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hyperlipidaemia,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Hypomagnesaemia,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Leukocytosis,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pancreatitis haemorrhagic,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pleural effusion,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pneumonia,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Pulmonary embolism,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Renal failure acute,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97776042,9777604,2,C,"EXENATIDE UNK STRENGTH PEN, DISPOSABLE DEVICE",1,,,,,,D,,,,,,,,2013,Q3,Tracheal stenosis,2013,Q3,2,F,20071210.0,20131217.0,20131222,20131222,EXP,US200903002757,BRISTOL MYERS SQUIBB,58.0,YR,F,Y,83.9,KG,20131222.0,,MD,US,US,2013,Q3,Adult
97861321,9786132,3,C,EXENATIDE,1,,"2 MG, OW",,,,D,,,,2,MG,INJECTION,/wk,2013,Q3,Mood swings,2013,Q3,1,I,20131212.0,20131220.0,20131227,20131227,PER,US-BAYER-2013-157907,BAYER,38.0,YR,F,Y,122.0,KG,20131227.0,,CN,US,US,2013,Q3,Adult
97861321,9786132,3,C,EXENATIDE,1,,"2 MG, OW",,,,D,,,,2,MG,INJECTION,/wk,2013,Q3,Product adhesion issue,2013,Q3,1,I,20131212.0,20131220.0,20131227,20131227,PER,US-BAYER-2013-157907,BAYER,38.0,YR,F,Y,122.0,KG,20131227.0,,CN,US,US,2013,Q3,Adult
97861321,9786132,3,C,EXENATIDE,1,,"2 MG, OW",,,,D,,,,2,MG,INJECTION,/wk,2013,Q3,Product physical issue,2013,Q3,1,I,20131212.0,20131220.0,20131227,20131227,PER,US-BAYER-2013-157907,BAYER,38.0,YR,F,Y,122.0,KG,20131227.0,,CN,US,US,2013,Q3,Adult
97861321,9786132,3,C,EXENATIDE,1,,"2 MG, OW",,,,D,,,,2,MG,INJECTION,/wk,2013,Q3,Skin odour abnormal,2013,Q3,1,I,20131212.0,20131220.0,20131227,20131227,PER,US-BAYER-2013-157907,BAYER,38.0,YR,F,Y,122.0,KG,20131227.0,,CN,US,US,2013,Q3,Adult
97861321,9786132,3,C,EXENATIDE,1,,"2 MG, OW",,,,D,,,,2,MG,INJECTION,/wk,2013,Q3,Sweat gland disorder,2013,Q3,1,I,20131212.0,20131220.0,20131227,20131227,PER,US-BAYER-2013-157907,BAYER,38.0,YR,F,Y,122.0,KG,20131227.0,,CN,US,US,2013,Q3,Adult
97908781,9790878,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,10,UG,,,2013,Q3,Pancreatitis,2013,Q3,1,I,201307.0,20131218.0,20131231,20131231,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19928605,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,,,20131231.0,,CN,GB,GB,2013,Q3,Elderly
97908781,9790878,1,PS,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,10,UG,,,2013,Q3,Respiratory failure,2013,Q3,1,I,201307.0,20131218.0,20131231,20131231,EXP,GB-BRISTOL-MYERS SQUIBB COMPANY-19928605,BRISTOL MYERS SQUIBB,68.0,YR,M,Y,,,20131231.0,,CN,GB,GB,2013,Q3,Elderly
